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Preface 
Christina Benighaus, DIALOGIK Stuttgart, Germany 
 
This book describes different possibilities of stakeholder involvement 
in the nature science research process. It summarizes the outlines and 
results of two stakeholder workshops of the OSIRIS project. OSIRIS 
will develop integrated testing strategies (ITS) fit for REACH. These 
enable to significantly increase the use of non-testing information for 
regulatory decision making, and thus to minimise the need for ani-
mal testing.  
The OSIRIS project aims to replace testing methods with non-testing 
strategies that provide results primarily based on computer model-
ling and simulation with a similar degree or even higher degree of 
validity and reliability than the results of experimental testing proce-
dures. Using computer models and other non-testing methods help to 
optimise efficiency, reduce overall costs, match the ambitious time 
schedule of the REACH regime and improve public acceptance due 
to less animal testing. OSIRIS will work with statistical models and 
data obtained from testing methods that promise fast, accurate and 
targeted information. A potential drawback of these new procedures 
is the possibility that unexpected outlayers remain unnoticed because 
computer models can only deduce inferences from existing knowl-
edge (reducing epistemic uncertainty) and random variations (reduc-
ing aleatory uncertainty). 
To ensure optimal uptake of the results obtained in this project, end-
users in industry and regulatory authorities (EU-stakeholders) have 
been invited to participate in the project, for example by becoming 
involved in monitoring and by providing specific technical contribu-
tions. 
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A central component of the stakeholder involvement strategy is the 
organisation of four workshops along the basic research steps. The 
workshops will highlight the different approaches and present the 
results of the project to key stakeholders. In this document, the out-
line and results of the first two workshops are described. 
The first Expert Workshop took place in Stuttgart (Germany) at the 
Waldhotel Degerloch in November 2007 for two days. 24 scientific 
experts from industry, academia, and regulatory agencies attended 
the workshop. The first workshop aims at receiving feedback from 
the participants on the overall scientific approach and the main fram-
ing of the research. For this purpose, representatives of Pillar 4 coor-
dinated by Dr. J.J.M. (Han) van de Sandt, (TNO Quality of Life in 
Zeist) presented their research plans and asked for feedback from 
experts. This consultation was organized in the form of a Group Del-
phi. 
The second workshop was designed to provide an overview of pre-
liminary results and was scheduled for November 2008 in Brussels. 
The main topic of this workshop was the match between REACH 
requirements and the proposed methods to meet these requirements 
with respect to human and ecological endpoints. Major stakeholders 
from industry and civil society as well as a group of interdisciplinary 
experts from academia and government have been invited to provide 
valuable input to the OSIRIS team and to discuss the contributions of 
the OSIRIS research for the REACH characterization and risk assess-
ment process.  
This paper reports the structure of the first two workshops and its 
results. The first chapter characterizes the Group Delphi method and 
describes the results of one individual and two group surveys in the 
context of the Group Delphi. The outcomes of the first workshop are 
summarized in the last section. 
Chapter 2 characterizes the structure of the second workshop with 
presenters and opponents and World Café. The outcomes are de-
cribed in the following sections.  
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The workshops were part of pillar 4 of the integrated EU-Project 
OSIRIS which is coordinated by Dr. J.J.M. (Han) van de Sandt, TNO 
Quality of Life, Utrechtseweg 48, 3704 HE Zeist, The Netherlands. 
The project is funded by the European Commission within in the 6th 
Framework Programme under the theme "Global Change and Eco-
systems", coordinated by Prof. Dr. Gerrit Schüürmann at the Helm-
holtz Centre for Environmental Research (UFZ) in Leipzig.  
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1 First Stakeholder Workshop - 
Group Delphi  
Prof. Dr. Dr. h.c. Ortwin Renn, Dr. Michael Ruddat, Christina 
Benighaus, DIALOGIK Stuttgart, Germany 
Dr. Han van de Sandt, Prof. Dr. Kees van Leeuwen,  
Dr. Dinant Kroese, TNO Zeist, the Netherlands 
1.1 Summary  
The main aim of the first Expert Workshop of the OSIRIS project 
(‚Optimized Strategies for Risk Assessment of Industrial Chemicals 
through Integration of Non-Test and Test Information‛) was to re-
ceive feedback from the participants on the overall scientific ap-
proach and the main framing of the research within Pillar 4. The 
principle results of the Group Delphi were the following: 
 The participants agreed that it is highly important to develop 
integrated assessment strategies for (groups) of chemicals, using 
the different building blocks of ITS. Second place goes to the de-
velopment and evaluation of individual ITS building blocks for 
physicochemical, (eco)toxicological and exposure data, followed 
by building a set of databases (with experimental and other data) 
that can be used for many purposes in and outside of OSIRIS. 
 With respect to the output (products) of OSIRIS, operational ITSs 
for all endpoints, using a weight-of-evidence approach as well as 
operational overall ITS, also using a weight-of-evidence ap-
proach, should have priority. There was clear consensus that re-
productive toxicity has the highest ranking because of the num-
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ber of animals and costs involved. Local toxicity (skin, eye) got 
the lowest ranking from all four groups in the third Delphi 
round. 
 Data obtained from in vivo studies were seen as very important 
for inclusion in the ITSs, but OSIRIS should not put effort in gen-
erating in vivo data. The innovation of ITSs should be realized 
through non-testing approaches. No consensus could be reached 
in prioritizing of the building blocks of ITS. 
 Exposure and exposure categories, descriptions of categories of 
chemicals related to mode of toxic action and information of 
modes of toxic action (e.g. chemical reactivity) are the databases 
which were deemed most important in the future for (eco)toxicity 
and exposure assessment compared to today and should there-
fore be the focus of OSIRIS.  
 The OECD (Q)SAR Toolbox as well as the RIP’s should be con-
sidered by OSIRIS as being important ongoing international ef-
forts and efforts should be made to link the various activities. 
 There was high consensus among all four groups that data and 
model uncertainty should be included in a scoring system for 
data quality. 
1.2 Methods of the Group Delphi 
A Delphi process is aimed at obtaining a wide range of opinions 
among a group of experts (Turoff, 1970; Pill, 1971; Linstone and 
Turoff, 2002). The process is organized in four steps. In step 1, a ques-
tionnaire asks a group of distinguished scientists to rank or rate sev-
eral items, in this case different methods for data collection, testing 
and verification. The scientists provide their best estimate and assign 
a confidence interval to their answers. In step 2, the organizing team 
feeds back to each participant the scores of the whole group, includ-
ing medians, standard deviation and aggregated confidence intervals. 
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Each individual is then asked to perform the same task again, but 
now with the knowledge of the responses of all other participants. In 
step 3, this procedure is repeated until individuals do not change 
their assessment any more. In step 4, the organizer summarizes the 
results and articulates the conclusions. 
A variation of the classic Delphi method is the group Delphi (Webler 
et al, 1991). During a group Delphi all participants meet face to face 
and make the assessments in randomly assigned small groups of 
three or four. The groups whose average scores deviate most from 
the median of all other groups are requested to defend their position 
in a plenary session. Then the small groups are reshuffled and per-
form the same task again. This process can be iterated three or four 
times until no further significant changes are made. At the end of a 
Delphi process, one receives either a normal distribution of assess-
ments around a common median, a two- or three-peak distribution 
(signalling a majority and one or more minority votes) or a flat curve 
(which means that knowledge is insufficient to make any reliable 
assessment). 
The advantage of Delphi is that a serious effort has been invested in 
finding the common ground among the experts and in finding the 
reasons and arguments that cause differences in assessments. The 
disadvantage is that Delphis depend upon the quality and complete-
ness of the expertise and information brought into the process. In 
general, DIALOGIK has had mostly positive experiences with Delphi 
processes, particularly group Delphi. 
 
Literature  
Linstone, H. A. & Turoff, M. (Hrsg.). (2002). The Delphi Method: 
Techniques and Applications. New Jersey: Science and Tech-
nology University. 
Pill, J. (1971). The Delphi method: Substance, context, a critique and 
an anotated bibliography. Socio-Economic Planning Sciences, 5.  
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Turoff, M. (1970). The Design of a Policy Delphi. Technological Fore-
casting and Social Change, 2, 149-171. 
Webler, T., Levine, D., Rakel, H., Renn, O.: ‚The Group Delphi: A 
Novel Attempt at Reducing Uncertainty,‛ Technological Fore-
casting and Social Change, 39 (1991), 253-263. 
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1.3 Results of first round (Individual 
Delphi) 
In the first Delphi round, a questionnaire was sent to each participant 
nine days before the workshop. It consisted of six key topics includ-
ing one or more key questions each. The research team of DIALOGIK 
received 17 questionnaires. The results were summarized in an excel 
sheet which indicated the median value as well as the distribution of 
answers. This sheet together with a short presentation of the results 
formed the basis for the deliberations at the Group Delphi. Figure 1-1 
in Annex 2 on page 22 gives a short overview of the results. 
There was some clear consensus among the respondents on most 
topics. For example, on key topic 3 (3.1: Databases of Chemicals - 
Kind of databases) almost all experts fully agreed that all of the avail-
able databases should be included in the future for (eco)toxicity and 
exposure assessment. Also, the OECD toolbox and the RIP’s were 
rated as very important or important by a vast majority of the par-
ticipants. Almost every one agreed on the high importance of the 
OECD principles as part of key topic 4 (4.3: Quality of data – Criteria) 
for OSIRIS. Key topic 5 was also addressed in a similar fashion by 
almost all respondents. This section dealt with public access of results 
and the installation of an open website for ITS. With the exception of 
one single expert voice, all of them agreed that all scientific results 
should be made public available. 
On other topics the answers of the respondents differed, sometimes 
even dramatically. For example, on key topic 2 (2.1: Tools and in-
struments for testing strategies of OSIRIS - Building blocks of ITS), 
hazard data from structurally related chemicals (read-across), 
(Q)SARs and Threshold of Toxicological Concern got very high rates 
of approval whereas in vitro methods, non-guideline animal data and 
animal data generated according to accepted guidelines were rated as 
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less important by some experts and highly important by others. Re-
sponses to ‚non-guideline animal data‛ and ‚in vitro methods gener-
ated according to ‘suitable’ methodologies‛ varied considerably 
among the experts. There were five participants who believed in the 
usefulness of ‚non-guideline animal data‛ as a building block of ITS 
and six participants who believed in the usefulness of ‚in vitro meth-
ods generated according to ‘suitable’ methodologies‛, while the oth-
ers felt them to be less useful. 
There was only little variation in key topic 1 (1.1: Focus of OSIRIS). 
The development of integrated assessment strategies for (groups) of 
chemicals and generation of ITS procedures (IT-Tools and Guidance 
Documents) were rated by a vast majority as more important than the 
contribution to the generation of databases and development and 
evaluation of individual ITS building blocks. On key topic 4 (4.1: 
Quality of data - Quality parameters - Reliability), the identity, purity 
and source of substance, the availability of information on structural 
analogues and the substantiation of deviations from guidelines were 
top priorities in the eyes of most experts. Statistics, analytical meth-
ods and publication in peer-reviewed journals were rated as less im-
portant. The availability of the complete test report or exposure con-
siderations shows more expert dissent: Some experts see them as very 
important while others rate them as only partly important. 
In essence, the first individual questionnaire demonstrated an aston-
ishing degree of convergence for most issues. The variance was usu-
ally low and only few items were clearly controversial. The objective 
of the Group Delphi Rounds that were conducted after the individual 
data was displayed and explained was to investigate whether the 
response patterns remained stable under the condition of intensive 
discussions. 
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1.4 Results of next two rounds (Group 
Delphi) 
The first Group Delphi round took place after Dr. Dr. Han van de 
Sandt, Dr. Dinant Kroese and Prof. Dr. Ortwin Renn gave a short 
introduction to OSIRIS and explained the Delphi Method. In addi-
tion, Prof. Dr. C. J. (Kees) van Leeuwen presented the results of the 
individual Delphi round. 
Five small groups were formed by random selection consisting of 
four individuals. Each of the group was asked to fill out the same 
questionnaire that they had individually responded to in the individ-
ual survey. The groups were encouraged to discuss the meaning of 
the question and deliberate about the most suitable answers. As ex-
pected the group discussion revealed first that many participants 
associated different connotations with each question. Secondly, by 
looking more closely into each question more variance and disagree-
ment was produced. The five groups had about 1,5 hours time to 
discuss and give their ratings as a group vote. They were also free to 
add comments or refine the wording of the question. Once the groups 
had completed their task, the research team of DIALOGIK processed 
the data from the filled out questionnaires and provided a summary 
of the results for presentation during the plenary session. 
During the plenary, the moderator asked groups that deviated most 
from the median value on each question to justify their judgments. 
This way the discussion focused on the differences not the similari-
ties. Often differences were due to unclear formulation of the ques-
tion or to different connotations of the terms used in the questions or 
in the list of standardized response categories. Occasionally differ-
ences were the result of calibration problems with respect to response 
categories such as very important versus important. There were only 
few questions where respondents had polarized views or were at the 
opposite end of the response scale. Yet there were quite a few signifi-
cant variations in the middle range of the answer categories. 
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Those questions that did not produce any significant disagreement 
were scraped from the next round of deliberation. For example, the 
central role of the OECD principles as a basis for (Q)SAR tools in 
OSIRIS was unchallenged in all groups. There was also unanimous 
support for the desired public availability of methodologies, data-
bases and the webtool for ITS. Both questions were therefore left out 
in the third round. The questions that seemed ambiguous were re-
formulated and many response categories were further specified. 
Several rating scales (from not important to very important) were 
transformed into ranking scales to force respondents to set priorities. 
Finally, additional questions were added where needed and new 
scales introduced. Once the new questionnaire was completed, a sec-
ond group round was organized. This time the composition of the 
group was permutated so that each new group consisted of at least 
one member of the four groups in the first round. Since the total 
number of participants was 20, a complete permutation was not pos-
sible but this objective could be widely met by composing a total of 
four groups with five participants each. 
Overall, the ratio of consensus to dissent decreased from 1,4 to 0,5 
between the individual and the first group round. This was mainly 
due to the discussion about the meaning of terms and the intention of 
the OSIRIS team. After carefully reformulating the ambiguous ques-
tions, generating new ones and introducing additional scales, the 
consensus/dissent-ratio increased to 3 indicating that consensual 
votes occurred three times more frequently than dissenting views. 
This comparison includes the consensual responses of round 1, which 
were deleted for the second Round of the Group Delphi. This is indi-
cated by ‚– ()‛. Also important to notice is that dissent does not 
necessarily mean substantive dissent or difference in judgments. Very 
often misunderstanding, misinterpretations, different connotations of 
terminology or ambiguities in the response categories were most 
frequently the source of the differences. Those problems could be 
resolved in the plenary discussion.  
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One can briefly summarize the final results after round 3 as follows: 
 The participants agreed that it is highly important to develop 
integrated assessment strategies for (groups) of chemicals, using 
the different building blocks of ITS. Second place goes to the de-
velopment and evaluation of individual ITS building blocks for 
physicochemical, (eco)toxicological and exposure data, followed 
by building a set of databases (with experimental and other data) 
that can be used for many purposes in and outside of OSIRIS. 
 No definite statement on the conditions for success of OSIRIS 
could be formulated, but the actual use of the OSIRIS tool in prac-
tice (by industry and regulators) should be the main aim of the 
project. 
 With respect to the output (products) of OSIRIS, operational ITSs 
for all endpoints, using a weight-of-evidence approach as well as 
operational overall ITS, also using a weight-of-evidence ap-
proach, should have priority. There was clear consensus that re-
productive toxicity has the highest ranking because of the num-
ber of animals and costs involved. Due to its toxicological com-
plexity, it was realized that developing an innovative ITS for this 
endpoint is a challenge, both from a scientific and regulatory ac-
ceptance point of view. Local toxicity (skin, eye) got the lowest 
ranking from all four groups in the third Delphi round. 
 No consensus could be reached in prioritizing of the building 
blocks of ITS, but some conditional remarks came up during the 
plenary discussion, which reduced the degree of dissent. For ex-
ample, when high quality data is available for hazard data from 
structurally related chemicals (read-across), then all groups as-
signed a high degree of relevance to the building blocks; however 
if not, the relevance was seen as less pronounced. Data obtained 
from in vivo studies were seen as very important for inclusion in 
the ITSs, but OSIRIS should not put effort in generating in vivo 
data. The innovation of ITSs should be realized through non-
testing approaches. 
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 Exposure and exposure categories, descriptions of categories of 
chemicals related to mode of toxic action and information of 
modes of toxic action (e.g. chemical reactivity) are the databases 
which were deemed most important in the future for (eco)toxicity 
and exposure assessment compared to today and should there-
fore be the focus of OSIRIS. This was the common judgment of 
tall four groups as the result of the third Delphi round. 
 The OECD (Q)SAR Toolbox as well as the RIP’s should be con-
sidered by OSIRIS as being important ongoing international ef-
forts and efforts should be made to link the various activities. 
 There was high consensus among all four groups that data and 
model uncertainty should be included in a scoring system for  
 data quality. 
 
The participants added many comments and specifications, which 
were all recorded by the research team. The group results and com-
ments are shown in Figures 1-3 and 1-4 in Annex 2 on page 33 and 41, 
respectively. Please note that for priority judgments the first digit 
indicates the number of the group, while the second digit indicates 
priority. For example ‚3,1‛ means that group number 3 gave this item 
first priority. 
1.5 Concluding remarks 
The Delphi exercise demonstrated the importance of structured dis-
cussion about terms and categories as the individual responses indi-
cated a degree of consensus that did not reflect the true representa-
tion of the respondents’ views. The process of small group judgment 
and plenary justification for explaining group differences lead to a 
more precise wording of the issues and topics and helped the OSIRIS 
research team to gain a better view of the priorities that the partici-
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pants assigned to the different tasks and activities. Furthermore new 
topics were introduced in the group discussions that added more 
depth to the analysis. 
The results of the Group Delphi will have an impact on the protocol 
and agenda of Pillar 4. Since the respondents made clear choices with 
respect to priorities, the research team can concentrate on those tasks 
that all respondents felt of having high importance to the OSIRIS 
overall objectives. In addition, the team has gained a better under-
standing of the preferences of the respondents and are better in-
formed about their needs. Finally, the respondents approved of the 
main tasks and planned activities of Pillar 4, which represents a pow-
erful message to the team that they are on the right track. 
1.6 Annexes: Additional comments, 
Tables & Agenda 
Annex 1: Additional comments 
A: PD Dr. Jan Ahlers, Federal Environmental Agency, Dessau, Germany, 
member of the OSIRIS Advisory Board 
 
 The target of OSIRIS was defined in ‚substitution of vertebrate 
testing‛, which in my understanding is far too narrow.  
Although definitely substitution of vertebrate tests is - beside protec-
tion of man and the environment - an important issue of REACH, I 
interpret the objectives of OSIRIS 
 ‚OSIRIS will undertake distinct research <, and their integration 
in a decision theory framework‛ or 
 ‚The OSIRIS project will develop ITS <.to significantly increase 
the use of non-testing information for regulatory decision mak-
ing‛, (flyer of the workshop) 
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 <‛minimizing the need for new testing in risk assessment pro-
cedures‛ (Objective Pillar 4) 
In a broader way. At least two additional items are rather important: 
1. substitution of non-vertebrate testing (e.g. tests for soil and sedi-
ment organisms) will help to save time and costs and even more 
important integrating alternative information enables us to per-
form a more comprehensive and faster assessment of these com-
partments and thus will certainly be an important contribution to 
environmental protection. 
2. The information obtained from alternative methods should not 
only be used for testing strategies, but should also be introduced 
in risk assessment. It can contribute considerably in reducing un-
certainty in regulatory decision making. 
 
B: Dr. Monika Nendza, Analytical Laboratory Luhnstedt, Germany 
 
As agreed, I comment on the QSAR principles: 
1. I agree with the OECD criteria for QSARs, I only have same res-
ervations about their practical use. 
2. 'Unambiguous algorithm' is a good idea with regard to transpar-
ency, but may not be realizable (i) with modern statistics, e.g., 
multivariate procedures with continuous update of databases or 
(ii) in case of proprietary models (with independent external 
validation). 
3. 'Defined applicability domain' is currently often restricted to 
chemical domain and as such may be misleading: It may pretend 
confidence in a model but that is not substantiated because other 
(more) important aspects of similarity / dissimilarity are ne-
glected (e.g. toxicological domain, mode of (inter)action). 
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Annex 2: Tables 
Fig. 1-1: Results of first Delphi round (n =17) 
Key Topic 1 (KT1): Focus of OSIRIS (1.1) 
1.1 What should OSIRIS do? 
  Very im-
portant 
Important 
Partly 
important 
Not impor-
tant at all 
Contribute to the generation 
of databases 
6 5 5 1 
Develop integrated assess-
ment strategies for (groups) 
of chemicals 
11 4 2 0 
Develop and evaluate indi-
vidual ITS building blocks 
7 9 1 0 
Generate ITS procedures (IT-
Tools and Guidance Docu-
ments) 
11 5 1 0 
KT1: Output of OSIRIS (1.1) 
1.1 What should OSIRIS do? 
  Very im-
portant 
Important 
Partly 
important 
Not impor-
tant at all 
Summaries of evaluated 
experimental data following 
the OECD Guidelines for the 
testing of chemicals. 
5 6 4 2 
Estimates of individual fate 
and (eco)toxicity data includ-
ing information about the  
uncertainty of the predic-
tions. 
5 8 3 1 
Generation of PNEC and 
DNEL information. 
3 4 7 3 
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KT2: Tools and instruments for testing strategies of OSIRIS - 
Building blocks of ITS (2.1) 
2.1 Existing tools in OSIRIS: Which of the tools below for generating fate 
and (eco)toxicity information are important for the testing strategies in the 
REACH process and should be included in Pillar 4? 
  Very impor-
tant 
Important 
Partly       
important 
Not important 
at all 
Animal data 
generated 
according to 
accepted guide-
lines 
6 7 3 0 
Non-guideline 
animal data 
5 5 5 1 
In vitro meth-
ods generated 
according to 
validated 
methodologies 
7 6 2 1 
In vitro meth-
ods generated 
according to 
‘suitable’ 
methodologies 
6 5 5 0 
Hazard data 
from structur-
ally related 
chemicals 
(read-across) 
9 5 1 1 
(Q)SARs 9 6 1 0 
Threshold of 
Toxicological 
Concern 
10 4 2 0 
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KT3: Databases of Chemicals - Kind of databases (3.1) 
3.1 Which databases should be included in the future for (eco)toxicity and 
exposure assessment? 
  
Fully agree Partly agree Partly disagree Fully disagree 
Exposure and 
exposure cate-
gories 
12 3 1 1 
Descriptions of 
categories of 
chemicals 
related to mode 
of toxic action 
14 3 0 0 
Physicochemi-
cal properties 
13 3 1 0 
Toxicity data 14 3 0 0 
Ecotoxicity 
data 
13 4 0 0 
Information of 
modes of toxic 
action  
12 5 0 0 
Estimates of 
fate and 
(eco)toxicity 
data including 
an estimate of 
their uncer-
tainty  
11 4 1 1 
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KT3: Databases of Chemicals - International activities (3.2) 
3.2 OSIRIS aims at being complementary to ongoing international efforts, 
such as the REACH Implementation Projects (RIP’s) and further activities. 
How do you rate the importance of the RIP’s, OECD QSAR toolbox and 
others? What other international activities are important for OSIRIS? 
  Very impor-
tant 
Important 
Partly       
important 
Not import-ant 
at all 
Reach imple-
mentation 
Projects RIP’s 
13 3 1 0 
OECD QSAR 
toolbox 
13 3 1 0 
KT3: Databases of Chemicals - Databases needed (3.3) 
3.3 What kind of databases has priority? 
  Very impor-
tant 
Important 
Partly       
important 
Not import-ant 
at all 
Local toxicity 
(skin, eye) 
4 5 4 0 
Reproductive 
toxicity 
13 4 0 0 
Aquatic toxic-
ity 
7 7 3 0 
Chronic toxic-
ity 
11 5 1 0 
Carcinogenicity 8 5 2 0 
Repeated dose 
toxicity (90-d) 
10 4 1 0 
26 Benighaus (Ed.): Stakeholder Involvement and Dissemination 
 
 
KT 4: Quality of data - Quality parameters (Reliability, 4.1) 
4.1 What information about the data in OSIRIS is, according to you, needed 
from a scientific and regulatory point of view? 
  
Very impor-
tant 
Important 
Partly       
important 
Not important 
at all 
Availability of 
complete test 
report 
6 6 5 0 
Substantiation 
of deviations 
from guidelines 
8 8 1 0 
In case of non-
guideline 
studies: publi-
cation in a 
peer-reviewed 
journal 
2 11 2 1 
In case of non-
guideline 
studies: inter-
pretation of 
results (alone 
or in combina-
tion)? 
7 5 3 0 
Performance of 
the study 
according to 
GLP 
1 7 9 0 
Identity, purity 
and source of 
substance 
10 7 0 0 
Exposure 
considerations 
4 10 3 0 
Analytical 
methods 
2 10 5 0 
Statistics 1 11 5 0 
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Availability of 
information on 
structural 
analogues 
9 4 3 1 
KT 4: Quality of data - Quality parameters (Relevance, 4.1) 
4.1 What information about the data in OSIRIS is, according to you, needed 
from a scientific and regulatory point of view? 
  Very impor-
tant 
Important 
Partly       
important 
Not important 
at all 
Animal species 3 13 1 0 
Route of ad-
ministration 
6 10 1 0 
Effect (with 
regard to target 
population) 
6 10 0 0 
KT 4: Quality of data - Quality aspect (4.2) 
4.2 Do you believe that Klimisch (1997) is useful for this purpose? Which 
aspect do you consider important for a scoring system? 
  Very impor-
tant 
Important 
Partly       
important 
Not important 
at all 
Data uncer-
tainty 
8 5 0 0 
Model uncer-
tainty 
5 7 1 0 
Representa-
tiveness of 
results (gener-
alisability) 
6 7 1 0 
Stochastic 
effects 
0 6 5 0 
Outlayers and 
surprises 
2 9 3 0 
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Effects on 
specific ecosys-
tems 
2 4 4 1 
KT 4: Quality of data - Criteria (OECD principles, 4.3) 
4.3 OSIRIS aims at basing the (Q)SAR tools on the OECD principles. Do 
you agree? 
  Fully agree Partly agree Partly disagree Fully disagree 
‚a defined 
endpoint‛ 
17 0 0 0 
‚an unambigu-
ous algorithm‛; 
15 2 0 0 
‚a defined 
applicability 
domain‛; 
15 0 2 0 
‚goodness-of-
fit, robustness 
and prediction 
power‛ 
16 1 0 0 
‚a mechanistic 
interpretation, 
if possible‛ 
14 3 0 0 
KT 5: Public availability 
5.1 OSIRIS aims at developing a webtool which is publicly available. Do you 
agree? Which elements need special attention with respect to confidentiality 
and ownership? 
  Publicicly 
available 
Should not be 
available 
  
Methodologies 17 0   
Databases 17 0   
Webtool 16 1   
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KT 6: Support for industry and regulation 
6.1 How can we support industry and regulators in providing effective and 
efficient testing methods and procedures in a timely manner? 
  Very impor-
tant 
Important 
Partly       
important 
Not important 
at all 
Demo version 
of the OSIRIS 
webtool 
10 5 0 1 
 
Fig. 1-2 - Overview over consensus and dissent in Delphi rounds 1 
– 3 (consensus () and dissent ()) 
Legend: Individual Delphi (ID, round (rou.) 1) and Group Delphi 
(GD), round (rou.) 2 and 3, n =17 persons for individual Delphi, n = 5 
groups for first Group Delphi, n = 4 groups for second Group Delphi, 
=consensus,  = dissent, - = question not posed in this round, - () 
= consensus from round 2, because of that question not posed again 
in round 3. 
 ID 
rou. 
1 
GD 
rou.
2 
GD 
rou. 
3 
Key 
Topic 1: 
Focus 
and 
Output 
of 
OSIRIS 
Focus of 
OSIRIS 
(1.1) 
What should OSIRIS do?   - 
What should be the priorities 
for OSIRIS? 
- -  
What are the conditions for 
the success of OSIRIS? 
- -  
Output 
of 
OSIRIS 
(1.1) 
What should OSIRIS do?   - 
What should have priority 
with respect to the output 
(products) of OSIRIS? 
- -  
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Key 
Topic 2: 
Building 
blocks of 
ITS 
Build-
ing 
blocks 
of ITS 
(2.1) / 
Existing 
tools in 
OSIRIS:  
Existing tools in OSIRIS: 
Which of the tools below for 
generating fate and 
(eco)toxicity information are 
important for the testing 
strategies in the REACH 
process and should be in-
cluded in Pillar 4? 
  - 
What building blocks should 
be developed preferentially 
for inclusion in ITS? 
- -  
Key 
Topic 3: 
Data-
bases of 
Chemi-
cals 
Kind of 
data-
bases 
(3.1) 
Which databases should be 
included in the future for 
(eco)toxicity and exposure 
assessment? 
  - 
Which databases will be 
more important in the future 
for (eco)toxicity and expo-
sure assessment than today? 
- -  
Interna-
tional 
activi-
ties (3.2) 
How do you rate the impor-
tance of the RIP’s, OECD 
QSAR toolbox and others? 
What other international 
activities are important for 
OSIRIS? 
  - 
Which ongoing international 
efforts should be considered 
by OSIRIS? 
 
 
- -  
Benighaus (Ed.): Stakeholder Involvement and Dissemination 31 
 
 
Data-
bases 
needed 
(3.3) 
What kind of databases has 
priority? 
  - 
On what data-
bases/endpoints should 
OSIRIS focus in order to 
reduce or replace vertebrate 
testing? 
- -  
Key 
Topic 4: 
Quality 
of data 
Quality 
parame-
ters (Re-
liability, 
4.1):  
What information about the 
data in OSIRIS is, according 
to you, needed from a scien-
tific and regulatory point of 
view? 
  
- 
() 
Quality 
parame-
ters 
(Rele-
vance, 
4.1):  
What information about the 
data in OSIRIS is, according 
to you, needed from a scien-
tific and regulatory point of 
view? 
  
- 
() 
Quality 
aspect 
(4.2):  
Which aspect do you con-
sider important for a scoring 
system? 
  - 
Risk assessors use scoring 
systems to assess the quality 
of the available information. 
Which aspect do you con-
sider important with respect 
to a scoring system? 
- -  
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Criteria 
(OECD 
princi-
ples, 
4.3):  
OSIRIS aims at basing the 
(Q)SAR tools on the OECD 
principles. Do you agree? 
  
- 
() 
Key 
Topic 5: 
Public 
avail-
ability 
OSIRIS aims at developing a webtool 
which is publicly available. Do you 
agree? Which elements need special at-
tention with respect to confidentiality 
and ownership? 
  
- 
() 
Key 
Topic 6: 
Support 
for in-
dustry 
and 
regula-
tion 
How can we support industry and regu-
lators in providing effective and efficient 
testing methods and procedures in a 
timely manner? 
  - 
How can we support industry and regu-
lators in providing effective and efficient 
testing methods and procedures in a 
timely manner? Please be as specific as 
possible. 
- -  
 ID 
rou. 
1 
GD 
rou.
2 
GD 
rou. 
3 
 
Ratio of consensus / dissent total 
 
7 / 5 
= 
1,4 
 
4 / 8 
= 
0,5 
 
10 / 
3 = 
3 
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Fig. 1-3: Results of second Delphi round (n = 5) 
Key Topic 1: Focus and output of OSIRIS, What should OSIRIS all 
about? 
Focus of OSIRIS 
Very 
impor-
tant 
Impor-
tant 
Partly 
impor-
tant 
Not im-
portant 
at all 
to contribute to the 
generation of databases 
(experimental and 
estimated data) 
2 (?) 3/1/ 4 5 4 
the development of 
integrated assessment 
strategies for (groups) 
of chemicals, using the 
different building 
blocks of ITS  
3/1/2/ 4/ 5 1   
to develop and eva-
luate individual ITS 
building blocks for 
physicochemical, 
(eco)toxicological and 
exposure data 
1/ 2/ 4 3/1/ 5   
to generate ITS proce-
dures (IT-Tools and 
Guidance Documents) 
for integrating these 
building blocks into 
integrated strategies to 
estimate fate, effects 
and exposure informa-
tion.  
1/ 2/ 4/ 5 3   
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Output of OSIRIS 
Very 
impor-
tant 
Impor-
tant 
Partly 
impor-
tant 
Not im-
portant 
at all 
We want to have 
summaries of eva-
luated experimental 
data following the 
OECD Guidelines for 
the testing of chemicals 
 5 1/2/ 4 3/2 
We want to generate 
estimates of individual 
fate and (eco)toxicity 
data including infor-
mation about the  un-
certainty of the predic-
tions 
2/ 4/ 5 3/1   
We want to generate 
PNEC, and DNEL in-
formation 
 4 3/1/ 5 2 
Comment: yes (3), yes (2), yes (4) 
Note: Numbers indicate group positions. 
 
Key Topic 2:  Tools and instruments for testing strategies of 
OSIRIS 
Existing tools in OSIRIS: Which of the following tools for generating 
fate and (eco)toxicity information are important for the testing strate-
gies in the REACH process and should be included in Pillar 4? 
Building blocks of 
ITS 
Very im-
portant 
Important 
Partly 
important 
Not im-
portant at 
all 
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Animal data gener-
ated according to 
accepted guidelines 
3,1/2/ 5   1 
Non-guideline ani-
mal data 
3,2/2 1   
In vitro methods 
generated according 
to validated metho-
dologies 
3,4/2 1   
In vitro methods 
generated according 
to ‘suitable’ metho-
dologies 
3,6/2 1   
Hazard data from 
structurally related 
chemicals (read-
across) 
3,3/2/ 5 1   
(Q)SARs 3,7/2 1   
Threshold of Toxico-
logical Concern 
3,5/2 1   
Comment: yes (3), yes (2), yes (4), yes (5) 
New tools: Should new tools be developed for the REACH process? 
And if so which ones do you have in mind? Exposure tools for low 
exposure situation (3), Additions to OECD toolbox (3), TTC (3) 
Focus on sensitivity of tests (3) 
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Key Topic 3:  Databases of Chemicals 
Which databases should be included in the future for (eco)toxicity 
and exposure assessment? 
Kind of databases 
Fully 
agree 
Partly 
agree 
Partly 
disagree 
Fully 
disagree 
Exposure and expo-
sure categories 
3,1/2/4/ 5 1   
Descriptions of cate-
gories of chemicals 
related to mode of 
toxic action 
3,2/1/2 
/4/5 
   
Physicochemical 
properties 
3,3/1/2 
/4/5 
   
Toxicity data 
3,4/1/2/4/5
,1 
1   
Ecotoxicity data 3,5/1/2/4/5 1   
Information of 
modes of toxic action  
3,2 
(?)/1/2/4/5 
   
Estimates of fate and 
(eco)toxicity data 
including an estimate 
of their uncertainty  
3,6/2/4/5 1   
Comment: yes (4) 
OSIRIS aims at being complimentary to ongoing international efforts, 
such as the OECD QSAR toolbox. Do you agree and which efforts are 
relevant to OSIRIS according to you? 
International ac-
tivities 
Very im-
portant 
Important 
Partly 
important 
Not im-
portant at 
all 
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OECD QSAR tool-
box (steering 
group 3) 
3/1/2/4/5    
RIPs 3/1/2/5    
Fobig ECVAM 
data quality 
 3   
Health Canada 1/ 2 3   
Comment:Toxcase partly important (3), EU CESAR (2), Predictonics 
(2), EU projects (2), EPAA (2), industry projects (2), US PMV activities 
(4), Testguidelines OECD (5) 
What kind of databases has priority, considering that the OECD 
Toolbox is already strong in aquatic toxicity and some mammalian 
toxicity endpoints (e.g. Ames test and sensitization)? 
 
Databases needed 
Very im-
portant 
Important 
Partly 
important 
Not im-
portant at 
all 
Local toxicity (skin, 
eye) 
4  3/1/2  
Reproductive tox-
icity 
3/1/2/4/5    
Carcinogenicity 4/5 1/2 3  
Repeated dose 
toxicity (90-d) 
4/5 3/1/2   
Sensititation  3/1 2   
Comment: Aquatic tox (BCF, 3), Aquatic tox (1,very important), 
chronic tox (1, very important), mutagenicity (2), yes (4) 
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Key Topic 4: Quality of data 
What information about the data in OSIRIS is, according to you, 
needed from a scientific and regulatory point of view? 
Quality parameters 
Very 
impor-
tant 
Impor-
tant 
Partly 
impor-
tant 
Not im-
portant 
at all 
Reliability 
Availability of complete 
test report 
2 3/5 1/ 4  
Substantiation of devia-
tions from guidelines 
3/2 1/ 4/5   
In case of non-guideline 
studies: publication in a 
peer-reviewed journal 
 1/5 3/ 4  
In case of non-guideline 
studies: interpretation of 
results (alone or in com-
bination)? 
3 4/5 1  
Performance of the 
study according to GLP 
 5 3/1/ 2/ 4  
Identity, purity and 
source of substance 
3,1/ 4,1 1/5   
Exposure considerations 3,1/ 4 1/5 1  
Analytical methods  3/1/ 4/5   
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Statistics   3/1/ 4  
Availability of informa-
tion on structural ana-
logues 
3/1 4/5   
Relevance 
Animal species 2/ 4,1 3,3/1/5   
Route of administration 2/ 4 3,2/1/5   
Effect (with regard to 
target population) 3,1/ 2 1/ 4/5   
Comment: yes (3) 
In practice, risk assessors in industry, academia and governmental 
organizations may not have time to read all the details about the data 
sources and quality and may wish to use simple scoring systems for 
reliability. Do you believe that the Klimisch (1997) is useful for this 
purpose? Which aspect you consider important with respect to a scor-
ing system? 
Quality aspect 
Very 
impor-
tant 
Impor-
tant 
Partly 
impor-
tant 
Not im-
portant 
at all 
Data uncertainty 3,1/ 2/5 1/ 4   
Model uncertainty 3,3/ 2 1/ 4/5   
Representativeness of 
results (generalisability) 
3,4/ 2/ 4 1 5  
Stochastic effects ?? 3, 2/ 4 1 1  
Outlayers and surprises 3,2/ 2/ 4/5 1 1  
Effects on specific eco- 4  1/5 3 
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systems 
OSIRIS aims at basing the (Q)SAR tools on the OECD principles. Do 
you agree? 
Criteria (OECD princi-
ples) 
Fully 
agree 
Partly 
agree 
Partly 
disagree 
Fully 
disagree 
‚a defined endpoint‛ 
3/1/2,1/ 
4/5 
   
‚an unambiguous algo-
rithm‛; 
1/ 2/ 4/5 3   
‚a defined applicability 
domain‛; 
1/ 2,1/ 4/5  3*  
‚goodness-of-fit, robust-
ness and prediction 
power‛; 
3/2/5 1/ 4   
‚a mechanistic interpre-
tation, if possible‛. 
3/2/ 4/5 1   
Comment: yes (3) 
 
Key Topic 5: Public availability 
OSIRIS aims at developing a webtool which is publicly available. Do 
you agree? Which elements need special attention with respect to 
confidentiality and ownership? 
Information Publicicly available Why not? 
Methodologies 3/1/ 2/ 4/5  
Databases 3/1/ 4/5 Industrial restrictions 
Webtool 3/1/ 2/ 4/5  
Comment: yes (2) 
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Key Topic 6: Support for industry and regulation 
How can we support industry and regulators in providing effective 
and efficient testing methods and procedures in a timely manner? 
Effort 
Very  
important 
Important 
Partly  
important 
Not im-
portant at 
all 
Demo version of the 
OSIRIS webtool to 
get feedback and 
enhance implemen-
tation 
1/ 2/5 3/ 4   
Training 3/ 2    
Communication 3    
 
Fig.1-4: Results of Third Delphi Round (n = 4) 
Key Topic 1: Main Focus of OSIRIS:  What should be the priori-
ties for OSIRIS? 
Priorities of OSIRIS Rank 1 Rank 2 Rank 3  
To build a set of databases 
(with experimental and 
other data) that can be 
used for many purposes in 
and outside of Osiris 
  3/ 2/ 4/ 1  
To develop and evaluate 
individual ITS building 
blocks for physicochemical, 
(eco)toxicological and ex-
posure data 
 3/ 2/ 4/ 1   
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Priorities of OSIRIS Rank 1 Rank 2 Rank 3  
To develop integrated as-
sessment strategies for 
(groups) of chemicals, us-
ing the different building 
blocks of ITS  
3/ 2/ 4/ 1    
Others: yes (3), yes (2)  
Identify existing databases 
and see if they are suitable 
for the purpose of Osiris 
Comment: sequential rank-
ing 
 x   
What are the conditions 
for the success of OSIRIS? 
Rank 1 Rank 2 Rank 3 Rank 4 
To have existing testing 
data on relevant endpoints 
(in database format) 
3/2  4/1 
 
To have existing databases 
operational which are rele-
vant for IST 
3/4/1 1 2 
 
To have harmonized tem-
plates for quality assess-
ment of data 
1 3/2/4  
 
Others: yes (3) 
 Here conditions related to data 
 More success criteria such as acceptability, timeliness, easy im-
plementability, communicability 
 Integrate item 1 and 2 (very high rank) 
Benighaus (Ed.): Stakeholder Involvement and Dissemination 43 
 
 
What should have priority 
with respect to the output 
(products) of Osiris? 
Rank 1 Rank 2 Rank 3 Rank 4 
Operational ITSs for all end-
points, using a weight-of-
evidence approach. 
3/ 2/ 1 4   
Operational overall ITS, us-
ing a weight-ofevidence 
approach. 
3/2/4 1   
Summaries of assessment of 
adequacy of available infor-
mation based on OECD 
guidelines or non-guidelines 
studies. 
  3 (?)/ 1 4 
Summaries of assessment of 
adequacy of available non-
testing information including 
uncertainty of the predictions 
 1 3 (?)/ 4  
Comment: Input to the work or output? (input data. Needs to be reli-
able and adequate; Output was meant. Distinguish between ‚sum-
maries‛ on tools and on chemicals (related to guidance documents). 
Important: Transparency about the selection of tools and the adequa-
cy of information about chemicals. 
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Key Topic 2:  Tools and instruments for testing strategies of 
OSIRIS 
Existing tools in OSIRIS: What building blocks should be developed 
preferentially for inclusion in ITS? 
Building blocks of ITS 
1 = hightest priority 
9 = lowest priority 
Animal data generated according 
to accepted guidelines 
3,1/ 2,1/ 4,9/ 1,7: difference: a) it is 
needed in general b) it is not the 
focus of Osiris c) generating pri-
mary data is not purpose of Osiris 
Non-guideline animal data 3,2/ 2,2/ 4,7/ 1,5 
In vitro methods generated ac-
cording to validated methodolo-
gies 
3,4/ 2,7/ 4,6/ 1,4 
In vitro methods generated ac-
cording to ‘suitable’ methodolo-
gies 
3,4/ 2,8/ 4,5/ 1,3 depending on 
endpoints, if suitable, it is very 
important 
Hazard data from structurally 
related chemicals (read-across) 
3,3/ 2,3/ 4,1/ 1,1: if high quality 
data is there then high priority for 
all groups 
(Q)SARs 
3,6/ 2,6/ 4,2/ 1,1: again contingent 
on high quality data 
Threshold of Toxicological Con-
cern 
3,7/ 2,5/ 4,4/ 1,2: contingent on 
high quality data and perspective 
on Osiris contribution 
Human data 
3,8/ 2,9/ 4,8/ 1,6: low in the con-
text of Osiris; yet generally, of 
course, very important 
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Tool to estimate low level expo-
sure 
3,5/ 2,4/ 4,3/ 1,2: contingent on the 
ability to develop acceptable con-
cepts for low exposure: if so, then 
important 
Comment:  yes (4)  on the condition of having high quality data, dis-
sent is disappearing 
Two dimensions: (1) high priority in general  (2) priority for specific 
Osiris contribution 
Inclusion of a ‚environmental threshold of no concern‛ level 
Note: First number indicates group, second number indicates prior-
ity, for example 3,1 means that group number 3 gave first priority to 
the ITS building block. 
Two questions:  
1) How much emphasis should Osiris place on getting high quality 
data? 
 High emphasis on best data because it adds an increase in preci-
sion 
 Quality data is not necessarily connected with known databases 
 However, if that data is not available this should not a reason for 
abandon the respective activity 
2) How should Osiris deal with knowledge gaps? 
 REACH explicitly asks to include all relevant information even if 
they are of lower quality 
 One of the objectives is to develop methods to process lower 
quality data (need to characterize uncertainty and variability) 
 Degree of accuracy of data needed depends on purpose, context 
and application (for example labelling) 
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New tools: Should new tools be developed for the REACH process? 
And if so which ones do you have in mind? 
Tools: Exposure assessment tools including exposure scenarios with 
updated default values; TTC for non-food chemicals and for non-oral 
routes. (2) 
Comments: No need for new building blocks. Weight of evidence ap-
proach/ decision theory should be further developed. Guidance is 
rather needed than mandatory decision theory. Intelligent databases/ 
knowledge bases (for example: hyperlinks, data mining, intelligent 
routing, relational datasets, etc.). (4) 
 
 
Key Topic 3:  Databases of Chemicals 
Which databases will be more important in the future for 
(eco)toxicity and exposure assessment than today? 
Kind of databases 
1 = highest priority 
7 = lowest priority 
Exposure and exposure catego-
ries 
3,2/ 2,1/ 4,1 
Descriptions of categories of 
chemicals related to mode of toxic 
action 
3,1/ 2,3/ 4,2/ 1,2 
Physicochemical properties 3,5/ 2,4/ 4,3 
Toxicity data 3,6/ 2,6/ 4,6 
Ecotoxicity data 3,7/ 2,6/ 4,5 
Information of modes of toxic 
action (e.g. chemical reactivity) 
3,3/ 2,2/ 1,2 
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Estimates of fate and (eco)toxicity 
data including an estimate of 
their uncertainty  
3,4/ 2,6/ 4,4/ 1,1 
Comment: yes (4), yes (1). Comment: Uncertainty and Variability are 
very important, last item has two different targets (ecotoxicity) and 
uncertainty 
Comment: if we have uncertainty characterisation there is no priority 
Which ongoing international efforts should be considered by OSIRIS? 
International activities 1 = highest priority 
N = lowest priority 
Tools 
OECD QSAR toolbox 3,1/ 2,2/ 4,3 
RIP’s 3,2/ 2,1/ 4,1/ 1,1 
Test guidelines OECD 3,6/ 2,4/ 4,7 
EU CAESAR 3,4/ 2,3/ 4,5 
Health Canada 3,3/ 2,5/ 4,4 
Fobig/ECVAM data quality 3,5/ 2,7/ 4,6 
US-PMN-Activities 
It is wise for OSIRIS  to use the existing data bases 
and this one is worth considering (Group 4): Re-
sponse; this has been done already (1992); interest-
ing to revisit this database after OSIRIS is com-
pleted; also check how much “real” data is available 
3,7/ 2,6/ 4,3 
Data (distinction is not quite consistent) 
Predictomics: it lines up with the EU-FP: should 
mine them 
Low (3) 2,3/ 4,2 
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EU-FP: reprotect, Acute-tox, Sensitiv<.. Low (3) 2,2/ 4,2 
EPAA Low (3) 2,4 
Others: SIDS Data (2,1), yes (1)  
 
Should OSIRIS incorporate all existing tools and databases or should 
OSIRIS ensure simple communication with them (=full compatibil-
ity)?  
3. Ensure simple communication, no full incorporation 
1. same opinion 
2. same opinion 
4. same opinion (based  more on feasibility, and cost-efficiency not 
desirability) 
On what databases/endpoints should OSIRIS focus in order to reduce 
or replace vertebrate testing? 
Databases needed 
1 = highest priority 
7 = lowest priority 
Local toxicity (skin, eye) 3,7/ 2,8/ 4,7 
Reproductive toxicity 3,1/ 2,1/ 4,1/ 1,1 
Carcinogenicity 3,5/ 2,5/ 4,2/ 1,5 
Repeated dose toxicity  3,6/ 2,4/ 4,3/ 1,5 
Sensitisation 3,3/ 2,2/ 4,6/ 1,3 
Mutagenicity 3,2/ 2,6/ 4,4/ 1,2 
Aquatic tox (BCF) longterm (3) 3,4/ 2,7/ 4,5/ 1,5 
Others: Chronic aquatic toxicity (2,3)Carcinogenicity: related on number of 
chemicals = low priority; related animals per chemical higher priority, if 
multiplied – medium to low priority 
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Key Topic 4: Quality of data 
Risk assessors use scoring systems to assess the quality of the avail-
able information. Which aspect do you consider important with re-
spect to a scoring system? 
Quality aspect 
Should be 
included 
Should not 
be included 
Relevant, 
but not 
integratable 
Single studies 
Data uncertainty 3/ 2/ 4/ 1 (?)   
Model uncertainty 3/ 2/ 4/ 1 (?)   
Distinction between model 
uncertainty for non-testing 
data and data uncertainty 
for test data (Interspecies 
extrapolation not relevant 
in this context) 
   
Data sets 
Representativeness of re-
sults (generalisability) 
2/ 4  1 
Stochastic effects 
a) correlation versus 
causation 
b) is covered by out-
layers (percentiles) 
c) emphasis on ro-
bust systems that 
are resilient against 
outlayers 
 2/ 1 (4) 
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Outlayers and surprises 4/ 1 2 (4) 
Comment: yes (4) Different meanings of generalisability: across 
chemical domains, space, populations, ecosystems, machine learning 
capability 
 
 Outlayers and surprises cannot be scored yet it may detect other 
endpoints 
 Oulayers and surprises depend on the limitations of the research 
framing 
 Leverage points (these are crucial points that exert influence in a 
regression): dominate the slope 
 
Identify surprises: (intelligent) speculation, trial and error, 
What kind of information on uncertainty needs to be communicated 
to the regulators? 
Ask the regulators (1) 
 
Key Topic 6: Support for industry and regulation 
How can we support industry and regulators in providing effective 
and efficient testing methods and procedures in a timely manner? 
Please be as specific as possible. 
Effort 
Very 
impor-
tant 
Impor-
tant 
Partly 
impor-
tant 
Not im-
portant 
at all 
Demo version of the 
OSIRIS webtool to get 
feedback and enhance 
3/ 2 4/ 1   
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implementation 
Training 3/ 2/ 4/ 1    
Guidance documents 3/ 2 4/ 1   
Case examples 3 2/ 4/ 1   
Comment: yes (1): 
4: Two-way communication rather than just training; case examples 
could be part of the demo 
1: Beta version should be out to get feedback and acceptance; to be in 
accordance with REACH time lines (aggressive time line: so a real 
challenge; needs to have it ready in 2010-2011) 
How should the results of OSIRIS be evaluated after the project is 
completed? 
Criteria for success will be if the tool will be used by industry and 
regulators! (3) 
 Have a test case early on: Start early as possible with one. (1) 
What is the goal: how many replacements? How many accepted? 
How many used? 
 Usual evaluation processes are included (publication, peer re-
view). 
 Consistent and reproducible outcome. 
 International harmonisation on a global scale (starting with the 
EU).  
 Three goals: adequacy, acceptance and global implementation. 
BE REALISTIC!! AND HELP US TO MAKE THE GOALS BECOME 
TRUE! 
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Annex 3: Agenda 
Wednesday, 28th of November 2007 
 
13.00 On-site Registration 
14.00 Welcome and Introduction 
Dr. J.J. M. (Han) van de Sandt, TNO Quality of Life, Zeist, the 
Netherlands 
Prof. Dr. Ortwin Renn, DIALOGIK & University of Stuttgart, 
Germany 
 
14.15 OSIRIS Pillar 4: Envisioned products and procedure 
State of the art; focus and output of OSIRIS  
Dr. Han van de Sandt, TNO Quality of Life, Zeist, the Nether-
lands 
Questionnaire topics 2-6  
Dr. Dinant Kroese, TNO Quality of Life, the Netherlands 
Results of the questionnaire  
Prof. Dr. C. J. (Kees) van Leeuwen, TNO Quality of Life, the 
Netherlands 
 
15.15 Delphi method: aim and procedure 
Introduction to method 
Prof. Dr. Ortwin Renn, DIALOGIK & University of Stuttgart, 
Germany 
15.30 First Round: Group Experts Delphi: break out in smaller 
groups 
17.00 Coffee break 
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17.30 Plenary discussion: Justification of Group Results 
19.00 Adjourn, invitation for a joined dinner  
 
Thursday, 29th of November 2007 
9.15 Feedback from day 1 
Second Round: Group Experts Delphi: break out in 
smaller groups 
10.45 Coffee break 
11.15 Plenary Discussion: Justification of Group Results 
12.30 Lunch 
13.30 Third Round: Group Experts Delphi: break out in smaller 
groups 
14.30 Coffee break 
15.00 Plenary Discussion: Justification of Group Results 
15.30 Concluding Session: General Feedback 
16.00 End of the workshop 
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2 Second Stakeholder Workshop 
– Opponents and World Café  
Christina Benighaus, Dr. Michael Ruddat,  
Prof. Dr. Dr. h.c. Ortwin Renn 
2.1 Summary 
The 2nd Stakeholder Workshop in November 2008 in Brussels 
gave the participants an overview on the preliminary results of 
OSIRIS and the contributions to the hazard assessment and the 
risk assessment process. Experts from industry, academia and 
government presented the available testing methods and ex-
plained how they can be used in REACH. Invited critical com-
mentators and the audience discussed the pros and cons of the 
approaches taken by OISRIS to fit the REACH testing require-
ments and took stock of the merits and problems of ITS ap-
proaches.  
Integrated Testing Strategies (ITS) will give the opportunity to 
accelerate the use of non-testing information for regulatory deci-
sions making of chemicals without reducing the required level of 
safety. OSIRIS will develop approaches for the many-to-one re-
placements of animal tests, i.e. Integrated Testing Strategies (ITS). 
But using ITS will not entail one-by-one replacements, but several 
different approaches will be combined and integrated. A systemic 
combination of the testing strategies like in vitro testing, QSAR, 
read-across or TTC will help to develop innovative non-animal 
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approaches. One major requirement is to use contextual informa-
tion with category data, read across and Mode of Action informa-
tion. It was suggested to combine endpoints with specific tests, for 
example RDT and in vivo Mutagenicity. 
An important limiting factor in implementation of the ITS will be 
the level of uncertainty that one is willing to accept when apply-
ing the modified testing strategies. The new testing strategies 
demand a new concept dealing with uncertainty. The open ques-
tion remains of how much uncertainty one is willing to accept. 
The acceptance of uncertainty needs an integrated concept that 
links: 
 risk assessment with risk perception and socio-cultural proc-
essing of risk  
 physical risk analysis with financial, economic and social risk 
 risk theory with organizational capacity building and man-
agement competency. 
OSIRIS should take into account the extent of coverage of ‚chemi-
cal space‛ rather than considering chemicals individually. Look-
ing at chemical spaces can facilitate the selection of testing priori-
ties as a basis to advance testing methodologies. Exposure consid-
erations and in particular use categories are also influential factors 
for ranking chemicals. 
The participants recommended to define QA/QC (quality criteria) 
for new testing methods, old none GLP-data etc., to decide which 
data are available and which data can be used for which purpose. 
The criterion of data ‚quality‛ in the context of development of 
databases should inform predictive tool development. The weight 
of evidence should be assimilated across broader data sources, 
taking into account factors such as consistency, specificity, bio-
logical plausibility, etc. 
OSIRIS efforts should focus on ‘in time delivery’ of its tools and 
approaches targeted at substances with a registration deadline of 
December 2013. In order to be considered as an information 
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source for the 2013 substances OSIRIS should be functional al-
ready by end 2010. Deliverance end 2010 does allow the consortia 
to assess applicability & remaining uncertainty of the non-test 
information, and either take the decision whether to accept the 
non-test information as is, or start generation of Annex VII & VIII 
information prior to registration. 
Data from industry is needed both to develop the ITS and for 
meeting the regulatory requirements of REACH. Sharing data will 
be one of the important factors in reducing animal test and costs. 
The framework has to be easily accessible and user friendly. That 
means among others that the input information should be clearly 
captured, that the algorithms used are transparent, that the results 
are reproducible, and the outputs formatted in such a way that 
they are ready for use in REACH. Finally, OSIRIS should develop 
a vision how to deal with end-users when questions arise, or 
when bugs are discovered, and also how it will ensure sustained 
development, support and maintenance for the tool. 
OSIRIS should consider the political dimension with respect to 
the acceptance of ITS by, for example, ECHA, Member States or 
the EC. A new integrated concept interrelated with the different 
levels of uncertainty have to be accepted not only from the user 
side (mainly industry) but also from European (ECHA, Member 
States, ECVAM) and Non-European authorities.  
A business plan is needed to deal with many of the above chal-
lenges. The development and assessment process of ITS needs 
time. In order to gain confidence and continuous feedback for 
alternative testing methods from stakeholders, an open and 
transparent process is absolutely essential. 
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2.2 Concept and methods of the work-
shop 
Target group of second workshop  
The second workshop was designed to represent a broad audi-
ence (minimum 50 up to 100 participants), to disseminate results 
as well as to collect feedback from the participants. As partici-
pants DIALOGIK invited representatives from:  
 European Chemicals Agency (ECHA), European Chemicals 
Bureau (ECB), National Competent Authorities 
 EU industry (individual companies and sector groups),  
 NGOs (environmental groups, public health groups, con-
sumer groups) 
 Experts from universities and research institutes 
 Key internal and external OSIRIS partners of the consortium 
members 
 Advisory board members 
 Experts from related activities worldwide (OECD, US-EPA, 
Health Canada). 
 
Objectives and strategies of the workshop 
The overall objectives of the second workshop were: 
 to communicate and disseminate the preliminary results of 
the first one and a half years of research to key stakeholders 
 to discuss issues of handling application, uncertainty and 
limitations of the ITS. 
Secondary goals of the second workshop were: 
 to ensure early input of OSIRIS results into the ongoing 
REACH process 
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 to initiate a dialogue between the project members and the 
EU-stakeholders  
 to increase the acceptance of the proposed models, non-
testing methods, web-based tools and ITS. 
 
Subjects of the second workshop and working questions 
As explained above, the workshop addressed the topics of human 
and environmental toxicology and the exposure of the biological 
domain. It included the framework of the OSIRIS project and en-
visioned application in the REACH process. The subtopics of the 
second stakeholder workshop covered: 
 approaches of integrated testing strategies and their potential 
for REACH, such in vitro testing, QSAR’s, TTCs and read 
across, 
 REACH requirements and dealing with uncertainty, 
 benefits of OSIRIS for industry, NGOS and regulators in the 
European Union, and 
 replacement, refinement and reduction of animal testing  
 
The working groups were asked to deal with the following three 
questions: 
 Under which conditions are the proposed integrated testing 
strategies operational for being used under REACH? 
 Is the pool of existing information sufficient to conduct inte-
grated testing strategies and if not, which additional informa-
tion needs to be accumulated? 
 Can you reduce the amount of testing, especially animal test-
ing (reducing costs and time) without sacrificing accuracy, va-
lidity and reliability of the results? 
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2.2.1 Key Methods of the workshop 
The workshop was divided in three main parts, an introductory 
part to explain the basic approach of the team to risk assessment 
and ITS, a lecturing part with presenters and opponents in which 
the audience received detailed information about the project and 
ITS. This information was the main input to a general discussion 
and a question-and-answer period using the world café or carou-
sel method as a means to facilitate the exchange of arguments, 
comments and ideas. 
 
Welcome and introduction in the workshop and OSIRIS 
In the first part of the project the coordinator of the project, Prof. 
Dr. Gerrit Schüürmann and the coordinator of the EU-research 
programme, Dr. Georges Deschamps, introduced the OSIRIS pro-
ject and explained the risk assessment process in the framework 
of REACH. A representative of the European Chemicals Agency, 
Evelin Fabjan, listed the requirements of REACH as a reminder 
for the discussion to follow. 
 
Presenters and opponents: results and critical comments 
The second part of the workshop contained the lectures of the 
presenter and the opponent with respect to each major topic fol-
lowed by a plenary discussion. The Pillar leaders or his/her repre-
sentative (Mark Cronin, Dr. Dinant Kroese and Dr. Theo Ver-
meire) presented the preliminary results of the consortium after 
one and a half year research. The main topics of the agenda were: 
 ‚Human and environmental toxicity and exposure: results 
and critical points of the OSIRIS framework‛ and  
 ‚Integration of the components in the OSIRIS framework and 
use in the REACH process: results and critical points‛. 
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After each topical presentation, an opponent (Bette Meek and Dr. 
Watze de Wolf) pointed out critical issues and posed open ques-
tions. Both opponents focused on a handful of critical points, to 
which the presenters responded. The opponents were invited by 
the OSIRIS team in advance to stimulate the discussion. 
2.2.2 World Café 
DIALOGIK selected a special communication method called the 
carousel technique. This technique is a modification of the World 
Cafe Method1 and has been proven very effective in similar situa-
tions. It is well suited for involving large groups with more than 
20 people. It can be easily practiced and is flexible with respect to 
varying group compositions. It can be applied to solution-
oriented as well as evaluation-oriented topics.  
 
World Café Ambiance 
For informal and personal working atmosphere it is essential to 
create an environment that evokes the informal feeling of a café 
house. Therefore DIALOGIK tried to make the workshop rooms 
look like a Café Ambiance, with small tables designed to host four 
or five people. Less than four people at a table may not provide 
enough diversity of perspectives, more than five limits the 
amount of personal interaction. 
The Café tables were arranged in a staggered, random fashion 
rather than in neat rows. They looked like tables in a sidewalk 
café after it has been opened for a few hours. DIALOGIK placed 
                                                          
1 ‚Café Conversations are an easy-to-use method for creating a living 
network of collaborative dialogue around questions that matter in service 
of the real work.1‛ For a detailed description of the method, please have a 
look at the webpage of ‚the World Café‛ (www.theworldcafe.com).‛ 
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at least two large sheets of paper over each table cloth along with 
a mug filled with markers. Paper and pens encouraged scribbling, 
drawing, and connecting ideas. To honour the tradition of com-
munity and hospitality associated with a Cafe, DIALOGIK pro-
vided beverages and snacks, because a Café is not complete with-
out food and refreshments.2 
Host and travellers 
DIALOGIK invited four or five participants each to gather at the 
small Café-style tables and let them discuss three rounds of ap-
proximately 20-30 minutes. They worked on the three working 
questions mentioned above. DIALOGIK encouraged both table 
hosts and members to write key ideas on their tablecloths or to 
note key ideas on large index cards in the centre of the group. 
After the initial round of conversation, DIALOGIK asked one 
person to remain at the table as the ‚host‛ while the others served 
as travellers. The travellers carried key ideas, themes and ques-
tions to their new conversations tables. 
DIALOGIK asked the table host to welcome the new guests and 
briefly share the main ideas, themes and questions of the initial 
conversation. DIALOGIK encouraged guests to link and connect 
ideas coming from their previous table conversations - listening 
carefully and building on each other's contributions. 
By providing opportunities for the participants to move from one 
table to the next, they were able to link ideas, questions, and 
themes. At the end of the second round, all tables in the room 
were cross-pollinated with insights from prior conversations. In 
the third round people returned to their home (original) tables to 
synthesize their previous discoveries or they continued travelling 
                                                          
2 In according 2008 The World Café. Free to copy and distribute with 
acknowledgement & a link to: http://www.theworldcafe.com 
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to new tables, leaving the same host at the table.3‛ After three 
rounds of conversation, we asked the hosts of each table to share 
their impressions of the three rounds and draft some conclusions 
about the results for each of the three questions- These conclu-
sions were summarized on a flip-chart. One host per question 
presented then the shared insights to the audience at the end of 
the meeting. The audience were invited to comment on the re-
sults. However since all participants have been exposed to almost 
all conversations during the carousel methods, only a few 
amendments were made. 
2.3 Presentations4 
2.3.1 Introduction to OSIRIS, risk assess-
ment in REACH 
The OSIRIS Co-ordinator Gerrit Schüürmann (UFZ, Germany) 
opened the meeting by providing an outline of OSIRIS and ex-
plaining the context of the project in terms of the 3Rs-concept of 
Russell and Burch, i.e. Replacement, Reduction and Refinement of 
animal testing and the need to develop approaches for the many-
to-one replacement of animal tests, i.e. Integrated Testing Strate-
gies (ITS). Using ITS means therefore that there is no one-by-one 
                                                          
3
 In according 2008 The World Café. Free to copy and distribute with 
acknowledgement & a link to: http://www.theworldcafe.com 
 
4
 Parts of this chapter are written by Andrew Worth who summarized 
the presentations of the workshop. 
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replacement, but several different approaches are combined and 
considered instead. 
Then Georges Deschamps (European Commission, DG Science 
and Research), emphasised the global dimension of the risk as-
sessment and the need for international dialogue and communica-
tion. It was noted that the engagement of stakeholders is an im-
portant and integral part of OSIRIS. 
Evelin Fabjan (European Chemicals Agency, ECHA, Finland) 
gave an overview of the information requirements under REACH, 
on the basic principles of ITSs and emphasised the safety aspects 
and the importance of ITSs in REACH. She also indicated a num-
ber of outstanding needs for scientific development, including the 
need to:  
 integrate different methods/information  
 study the applicability of the Threshold of Toxicological Con-
cern (TTC) concept  
 gain more experience of quantitative read-across for human 
health endpoints and  
 have a readily accessible and reliable source of information on 
QSAR validity 
2.3.2 REACH: alternative testing - a new 
practical approach 
By Evelin Fabjan  
(European Chemicals Agency, ECHA, Finland) 
The REACH Regulation entered into force on 1st June 2007 with 
an aim to streamline and improve the former legislative frame-
work on chemicals of the European Union (EU). It places greater 
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responsibility on industry to manage the risks that chemicals may 
pose to the health and the environment. It requires manufacturers 
and importers of chemical substances (≥1 tonne/year) to obtain 
information on the physicochemical, health and environmental 
properties of their substances and to use this information to de-
termine and document how these substances can be used safely.  
In order to achieve a high level of protection of human health and 
the environment while limiting the need for additional testing, all 
available data on the intrinsic properties of a substance, including 
testing data (in vivo, in vitro) as well as non-testing data (ob-
tained with (Q)SAR models, grouping of substances, weight of 
evidence etc.) must be evaluated first. Annexes VI to X of the 
REACH Regulation specify the minimum data requirements for 
registration purposes according to the tonnage. The standard 
information set may be adapted according to the specific rules in 
column 2 of the above-mentioned Annexes and general rules de-
scribed in Annex XI of the REACH Regulation (e.g. in cases where 
testing is not technically possible, or testing does not appear sci-
entifically necessary, or based on exposure considerations). Where 
available data are not adequate to meet the requirements of the 
REACH Regulation, additional testing may be needed.  
Whereas the legislation provides the legal framework that regis-
trants need to follow when deciding if, when and what type of 
information needs to be submitted, to facilitate this, extensive 
guidance on integrated testing strategies was developed in close 
collaboration with experts from Member States, industry and 
NGO’s
5
.  
The presentation briefly outlined the information requirements 
under the REACH Regulation, the elements of integrated testing 
strategies (ITSs), their current applicability for human health end-
                                                          
5 Guidance on information requirements & Chemical Safety Assessment. 
http://guidance.echa.europa.eu/docs/guidance_document/information_re
quirements_en.htm?time=1233748148 
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points (based on the guidance documents), and summarised the 
main areas where further development is needed 
2.3.3 Human and environmental toxicity 
and exposure 
Human and environmental toxicity and exposure: results and 
critical points of the OSIRIS framework 
 
Presenter: Prof. Dr. Mark Cronin, School of Pharmacy and Chemistry, 
Liverpool John Moores University, UK 
 
Second Presenter: Dr. Theo Vermeire, National Institute of Public 
Health and the Environment - RIVM, Bilthoven, The Netherlands 
 
Opponent: Dr. Bette Meek, Chemical Risk Assessment, McLaughlin 
Centre for Population Health Risk Assessment, University of Ottawa, 
Canada 
 
Prof. Dr. Mark Cronin (Liverpool John Moores University, 
LJMU) gave an overview of progress made in pillar 2 (biological 
domain), e.g. the collection and structuring of toxicological data-
bases, evaluation of data quality, the application of mode and 
mechanism of action information in ITS, formation of categories 
for read-across and the optimisation of proposals for in vivo test-
ing. He emphasised the importance of, and difficulty, in establish-
ing the quality and adequacy of the test and non-test toxicological 
data. It was noted that adequacy is highly context and policy-
dependent. He also described ongoing work aimed at developing 
a better understanding of the role of mechanistic information in 
ITS. 
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Dr. Theo Vermeire (RIVM, NL) gave an overview of progress 
made in pillar 3 (exposure-informed testing), including both ex-
posure-based waiving (EBW) and exposure-based testing (EBT). 
He indicated that according to the legal text of REACH, the possi-
bilities for EBW are quite limited and the burden of proof is very 
high. EBW should be justified by a thorough exposure assess-
ment. However, he described that there are opportunities to ex-
plore the possible application of the TTC concept, as well as the 
Environmental Threshold of No Concern (ETNC) concept. He 
referred to both of these as instances of a more generic No Further 
Action Level (NFAL). He also described ongoing work aimed at 
the development of probabilistic modelling approaches for assess-
ing the relationship between exposure levels and NFALs. 
2.3.4 Exposure informed testing under 
REACH 
By Dr. Theo Vermeire1, Dr. Marja van de Bovenkamp1, Dr. 
Hans Marquart2 
1 National Institute of Public Health and the Environment (RIVM), Bilt-
hoven, The Netherlands 
2 TNO Quality of Life, Zeist, The Netherlands,  
Email contact: theo.vermeire@rivm.nl 
 
Introduction 
Within the REACH framework, but also within OECD, there is 
understanding that for reasons of animal welfare, costs and logis-
tics, it is important to limit the number of tests to be conducted. 
Integrated Testing Strategies (ITS) will make it possible to in-
crease the use of non-testing information for regulatory decision 
making of chemicals, and to effectively reduce animal testing 
without increasing the overall uncertainty. Exposure is one of the 
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decision elements in ITS. Testing can be waived triggered on the 
basis of exposure considerations. This presentation aims to de-
scribe criteria for exposure informed testing as foreseen in the 
REACH regulation and to give more detail to the REACH re-
quirements for exposure-based waiving. General guidance for 
Exposure Based Waiving is given in the REACH TGD Chapter R.5 
(Adaptations on information requirements). Besides, this presen-
tation is further based on research done within the EU Sixth 
Framework project OSIRIS (Optimized Strategies for Risk As-
sessment of Industrial Chemicals through Integration of Non-Test 
and Test Information). 
Exposure informed testing includes both Exposure Based Waiv-
ing (EBW) and Exposure Based Triggering (EBT). The principle 
behind any EBW is that there are situations when human or envi-
ronmental exposures are so low that there is a very low probabil-
ity that the acquisition of additional effect information may lead 
to an improvement in the ability to manage risk. In contrast, EBT 
refers to situations where human or environmental exposures are 
considered high enough to justify testing above the regulatory 
requirements.  
In the Annexes VII-X of REACH, specific rules are presented 
when standard toxicity testing, as specified in Annex VI, may be 
omitted, triggered, replaced or adapted. No possibilities for EBW 
exist below a tonnage of 10 tonnes per annum. Therefore, so-
called ‘column 2’ adaptations for EBW/EBT only come into play 
from Annex VIII. In addition, Annex XI, section 3, presents the 
possibility of the waiving of certain toxicity studies in Annex VIII 
(repeated dose toxicity, sub-chronic toxicity, reproductive toxic-
ity) and the tests in Annexes IX and X based on ‘the exposure 
scenario(s) developed in the Chemical Safety Report (‘substance-
tailored exposure driven testing’).  
This presentation will discuss the criteria for the justification for 
EBW and EBT, including (eco)toxicological reference values. Ex-
amples will be given for both human and environmental exposure 
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assessment. The consequences for exposure assessment method-
ology will also be presented.  
 
Results and discussion 
EBW and EBT can best be considered within the context of risk-
based decision making. Extensive and detailed knowledge of 
exposure throughout the life cycle for human and environmental 
exposure is essential for exposure informed testing. Human expo-
sure includes occupational exposure, consumer exposure and 
human exposure via the environment. For humans, both external 
and internal exposure should be considered. All stages in the life-
cycle of a chemical should be taken into account for a valid justifi-
cation of waiving: production, formulation, industrial or profes-
sional or private use, service life and disposal.  
The justification for EBW/EBT can be based on either a qualitative 
argumentation or a quantitative argumentation. Qualitative justi-
fication for EBW could be based on specific use or limited emis-
sions, on specific operational use or use conditions and on sub-
stance properties. Examples are: 
 Substances reacting away or binding covalently to a matrix  
 Use in strictly controlled, closed systems with extensive per-
sonal protective equipment (PPE)  
 Infrequent use 
 Substances with low volatility, fugacity. 
 Absorption is unlikely. 
If absence of exposure cannot be argumented in a qualitative 
sense, a quantitative exposure assessment and risk characteriza-
tion based on hazard and exposure may be needed, considering 
the exposure scenario developed in the Chemical Safety Report. 
Quantitative justification for EBW needs a assessment that expo-
sure is below a ‘no further action level’ such as PNECs (Predicted 
No-Effect Concentrations), DNELs (Derived No-Effect Levels), 
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DMELs (Derived Minimal-Effect Levels) or TTCs (Thresholds of 
Toxicological Concern). The ‘no further action level’ should be 
applicable even when little toxicological information is available 
for a substance and exposure via different routes and in different 
compartments should be taken into account. TTCs will be dis-
cussed separately in this symposium. The kinetics of the com-
pound (especially bioavailability) can refine the exposure estimate 
to justify EBW. 
Quantitative justification will further be based on exposure sce-
narios. An exposure scenario describes what a substance is used 
for, how it is used and under which operational conditions, and 
what risk management measures are taken to control the expo-
sure of man and the environment. The REACH Guidance details 
how an exposure scenario is built and how it is used for the expo-
sure assessment. The quantitative exposure estimate, obtained 
either by modelling or by measuring, and relevant to the test that 
is to be waived, will be compared to the ‘no further action level’. 
EBT requires the outcome of a Chemical Safety Assessment show-
ing risk levels that indicate the need for further research based on 
testing strategies such as in the REACH Guidance.    
Both the exposure estimate and the ‘no further action level’ are 
uncertain because of uncertainties and variability in scenarios, 
models, and parameters, leading theoretically to a distribution of 
risk characterization ratios (RCRs) like PEC/PNEC, Estimated 
Intake/DNEL, PEC/TTC, Estimated Intake/TTC. Therefore the real 
question is what the probability is that the estimated RCR is ex-
ceeding the trigger value of 1 and what probability of exceeding is 
acceptable to warrant the conclusion that EBW is justified. For 
instance, if the distribution is such that only the far right end of 
the exposure distribution is exceeding the trigger value, EBW may 
be acceptable. Also, a tier 1 realistic worst case assessment can be 
performed the result of which can be considered to be equivalent 
to a ‘far right end’ estimate. If a significant part of the distribution 
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exceeds the trigger value, EBW should be declined. Distributions 
far above one would trigger testing (EBT). 
The ‘no further action level’ can be very low, below levels for 
which methods have been developed and validity can be assumed 
to be reasonable. Therefore, it needs to be determined whether 
available methods and models can make a valid estimate of (very) 
low exposure, while incorporating the relevant parameters of the 
exposure scenarios with sufficient sensitivity. For measured and 
modeled data this means that the exposure situation used to de-
rive the exposure estimate should be comparable to the situation 
under study with respect to potential determinants of exposure. 
For modeling, additional criteria are that the model estimates 
exposure accurately given the exposure situation and that the 
model parameters can be estimated accurately. A selection of 
available models will be discussed in the light of these require-
ments: EUSES for the environment, Stoffenmanager, RISKOF-
DERM and ECETOC TRA for workers and CONSEXPO for con-
sumers. 
 
Conclusions 
In the justification for EBW a number of conditions should be met. 
First, it should be determined whether current exposure models 
and measurement data are suitable to accurately estimate expo-
sure in the lower exposure range. When valid exposure estimates 
or measurements are obtained, they should be compared to a 
relevant toxicological threshold to determine whether exposure is 
below the ‘no further action level’. Although some thresholds are 
available it is as yet unclear to what extent they meet the criteria 
stated above. This needs to be evaluated. In addition, it needs to 
be determined whether it is valid to assume that exposure to sub-
stances in REACH at levels below the given thresholds do not 
pose any risk. Further evaluation of the identified exposure sce-
narios that may give reason to EBW and EBT, using the model 
outcomes and measurements and the available toxicological 
Table 1 could look like this 
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thresholds, should give insight in the necessary improvements 
and criteria to make the EBW and EBT concept feasible.  
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2.3.5 Integrated testing strategies in the 
OSIRIS framework and use in the 
REACH process 
Integration of the components in the OSIRIS framework and 
use in the REACH process: results and critical points 
Presenter: Dr. Dinant Kroese, Chemical Safety, TNO Quality of Life, 
Zeist,The Netherlands 
Opponent: Dr. Watze de Wolf, Environmental Sciences Europe, Du-
Pont, Belgium 
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Dr. Dinant Kroese (TNO Quality of Life, The Netherlands) gave 
an overview of progress made in pillar 4 on integration of test and 
non-testing information: e.g. how to add (Q)SAR data, and in vitro 
data. He showed the need to develop a formal weight of evidence 
(WoE) framework for evaluating and documenting the integration 
of these different types of information that may be asked for in an 
endpoint ITS, and illustrated this for human health, but indicating 
that the same concept holds as well for environmental health. This 
should be happened in a transparent and objective manner to 
quantify uncertainties and resolve conflicting values.  
He also described ongoing investigations of the applicability of 
decision analysis (DA) and cost-effectiveness analysis (CEA) in 
the design and analysis of ITS. Ideally, in case endpoint-specific 
information is not yet considered sufficient (by the WoE ap-
proach), one should upfront be able to choose the optimal way – 
in terms of duration, cost, animal usage etc - of achieving the 
situation of sufficient information. 
Finally, he presented the OSIRIS webtool which is an important 
and challenging development in the project: this tool is to inte-
grate the ITS, WoE and to take account of DA and CEA considera-
tions. It should advise the user on the adequacy of information 
within ITS, and on whether provided information is sufficient or 
not. Though not fully crystallised yet, the idea is that this webtool 
should have access to publicly available databases, and be able to 
consider and import information from various sources, including 
those provided by the end user in a confidential way. 
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2.4 Results of the workshop 
2.4.1 Critical Comments of the opponents 
Bette Meek (University of Ottawa, Canada), a member of the 
OSIRIS advisory board, offered some insights and suggestions 
based on her substantial experience of the development of prior-
ity setting methods for the Canadian Domestic Substances List 
(DSL). According to the Canadian experience, exposure consid-
erations and in particular use categories had been very influential 
in ranking chemicals according to their concern. She also empha-
sised the importance of obtaining information on early effects and 
modes of action in the risk assessment process, and referred to a 
conceptual framework developed by the International Life Sci-
ences Institute (ILSI). Dr. Meek also noted the importance of char-
acterising the chemical space of regulatory inventories (especially 
the REACH inventory) and comparing this with the applicability 
domains of potentially useful QSAR models. 
 
Watze de Wolf (ECETOC, Belgium) suggested a number of suc-
cess criteria for judging the successful uptake of ITS, including the 
need to gain acceptance by all parties involved in the risk assess-
ment process and the sustainability of ITS tools, such as those 
developed within OSIRIS, beyond the end of the project in 2011. It 
was acknowledged that for ITS to gain widespread acceptance, all 
parties will need to embrace a change of mind-set, and transpar-
ent software tools will need to be openly accessible to all. 
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2.4.2 Comments to human and environ-
mental toxicity and exposure 
By Bette Meek, Associate Director, Chemical Risk Assess-
ment, McLaughlin Centre for Population Health Risk As-
sessment, University of Ottawa, (on Interchange from 
Health Canada),  
E-mail bmeek@uottawa.ca 
 
Comments offered here are based on experience acquired in meet-
ing the time limited legislated mandate in Canada to set priorities 
for health risk assessment and management from amongst the 23, 
000 compounds on the Domestic Substances List (DSL) under the 
Canadian Environmental Protection Act (i.e., ‚categorization‛). 
This exercise involved development and testing of predictive 
methodologies for both exposure and effect. 
Exposure 
One of the important observations from the categorization exer-
cise was the limited influence of quantity of production on poten-
tial for exposure, based on relatively simple exposure profiling 
conducted for all of the entries on the DSL. In fact, the nature and 
pattern of use of the chemical was far more influential, with a 
significant number of high volume production substances consid-
ered to present ‚lowest potential for human exposure‛.   
This observation likely has implications for exposure based waiv-
ing for the high production volume chemicals in Europe. In addi-
tion, the methodology which was developed to relatively rank 
potential for exposure for all 23, 000 chemicals on the Canadian 
DSL based on their production volume and use profile may be 
additionally helpful in this context.  For example, there is poten-
tial to quantify exposure based on this profiling (in addition to 
physical/chemical properties) through comparison with quantita-
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tive estimates for well characterized Priority Chemicals with simi-
lar use patterns and properties.  
I wished also to comment on some aspects related to the threshold 
of toxicological concern (TTC). While it offers potential in priority 
setting (including exposure based waiving), I believe that there 
are significant barriers to its widespread adoption, currently, the 
most important of which relates to transparency of the supporting 
underlying database on toxicity.  In addition, there seems to be 
limited understanding that the TTC represents essentially ‚negli-
gible exposure‛, based on consideration of relevant data in a 
manner similar to that which serves as the basis for quantitative 
structure activity relationship (QSAR) models. I particularly liked 
Theo’s characterization of the TTC in the context of a ‚no further 
action level‛. However, as per a number of commercially avail-
able (Q)SAR models, there is limited transparency concerning the 
nature of the relevant original data which support the TTC; de-
velopment of a software tool to enable users access to the relevant 
underlying primary toxicological data would likely contribute 
considerably to increasing understanding and its potential appli-
cation.  Certainly, the TTC may offer promise for consideration in 
the context of industrial chemicals though it was developed origi-
nally for application in relation to food additives, based on recent 
comparison of the ‚chemical space‛ of the underlying databases 
with that for the Canadian DSL.    
 
Biological Domain 
There is also potential to fairly efficiently identify chemicals 
which are relatively ‚non-toxic‛ based on hierarchical considera-
tion of available data on hazard and relatively conservative crite-
ria for dose-response for relevant endpoints. A tool of this nature 
developed for DSL categorization permitted efficient identifica-
tion of approximately 20% of the chemicals examined as not re-
quiring additional consideration with very limited investment of 
resources. 
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It will also be important to make optimum use of the available 
toxicological data since it is the limiting determinant of the poten-
tial contribution of (Q)SAR modelling and read across (including 
categories and analogues). The likely contribution of these inter-
dependent lines of evidence, in a predictive context particularly 
from a human health perspective is limited considerably by the 
extent of the existing dataset on their toxicity and its mining in a 
structure activity context. The limited information captured in 
databases that underlie some commercially available (Q)SAR 
models for complex endpoints such as developmental toxicity is 
simply inadequate to consider, for example, relationships be-
tween various endpoints and potential patterns of effects associ-
ated with specific modes of action. This issue has been considered 
recently in a project of the International Life Sciences Research 
Foundation funded by Health Canada and the U.S. Environ-
mental Protection Agency which brought together endpoint spe-
cialists, (Q)SAR model developers and risk assessors, as a basis to 
design and populate a database to better inform (Q)SAR model-
ling for this endpoint.  
It’s also critically important to reconsider the criterion of data 
‚quality‛ in the context of development of databases as a basis to 
inform predictive tool development. Objectives are necessarily 
considerably different than that for which rather narrow reliabil-
ity criteria (e.g., Klimisch) have been applied in the past in the 
consideration of individual toxicity studies. Rather, what is criti-
cally relevant in this context is assimilation of the weight of evi-
dence across broader data sources, taking into account factors 
such as consistency, specificity, biological plausibility, etc.    
The need for early consideration of mode (mechanism) of action 
in the development of efficient and integrated test strategies is 
also critical. Indeed, the lack of same in previous traditional test-
ing strategies for hazard for human health endpoints has severely 
limited the potential value of available data on hazard in the de-
velopment of predictive tools. The sole possible exception is can-
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cer/genotoxicity (in particular for DNA-reactive carcinogens), for 
which there is at least crude consideration of how the chemical 
may be inducing the effect.  In fact, it is envisaged that chemicals 
may be more meaningfully grouped for further consideration in 
future based on their genomic profiles. These profiles can be fur-
ther linked to early key events for particular modes of action for 
critical effects; focus on early key events in a mode of action con-
tinuum (versus measures of overt toxicity) should in future obvi-
ate the need for longer term studies.  
 
Also, rather than considering chemicals individually, there is a 
need to take into account the extent of coverage of ‚chemical 
space‛ in determining testing priorities, as a basis to advance 
predictive methodologies. 
2.4.3 Comments to integration of compo-
nents in the OSIRIS framework & 
use in the REACH process 
By Dr. Watze de Wolf, ECETOC, Av. E. Van 
Nieuwenhuyse 4, B-1160 Brussels 
Member ECETOC Scientific Committee, Director Health & Environ-
mental Sciences, DuPont 
 
Comments offered are based on experiences acquired in prepar-
ing an industrial chemicals company for REACH, as well as ex-
periences in the use of non-testing information in research and 
development activities. 
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OSIRIS Elements for Success 
Several points are critical to successful application of the OSIRIS 
framework in the context of the new EU chemicals legislation 
REACH.   
First and foremost the endpoints addressed in OSIRIS need to 
match the information requirements as stipulated in the different 
annexes of REACH. The challenge lies not with the development 
of non-test approaches for environmental endpoints, or local and 
acute toxicity endpoints. However, repeat dose toxicity is where 
most animals are used. Non-test information is expected to have 
the most significant animal-use reduction potential for reproduc-
tive toxicity assessment.   
OSIRIS efforts should focus on ‘in time delivery’ of its tools and 
approaches targeted at substances with a registration deadline of 
December 2013.  It is unrealistic to expect an impact for sub-
stances with a registration deadline of end 2010. For these sub-
stances the information requirements need to be fulfilled already 
mid 2009 to allow the Consortia to finish their hazard assessment 
part of the Chemical Safety Report end 2009, thus allowing just 
enough time for the exposure assessment and subsequent regis-
tration dossier submission by the Lead Registrant by mid 2010. In 
order to be considered as an information source for the 2013 sub-
stances OSIRIS should be functional already by end 2010.  
Deliverance end 2010 does allow the consortia to assess applica-
bility & remaining uncertainty of the non-test information, and 
either take the decision whether to accept the non-test information 
as is, or start generation of Annex VII & VIII information prior to 
registration. Within industry these decisions are not only made by 
scientists, who can assess the technical merits of the non-test in-
formation, but also by business decision makers (risk managers). 
The latter group will have to balance the risk of non-acceptance 
by the authorities in the context of their overall business planning.  
Are they willing and able to accept the residual uncertainties and 
the potential that their scientists will have to spend (extended) 
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time and resources in interpretation discussions with ECHA rep-
resentatives? 
Acceptability considerations are not restricted to industry and 
ECHA as the sole actors. In a growing global world hazard infor-
mation has no regulatory or geographical boundaries.  Hence, 
other authorities such as for instance EFSA, FDA, US EPA, Health 
& Environment Canada make use of the same hazard informa-
tion. Hence, OECD activities on Mutual Acceptance of Data, and 
the development (Q)SAR Toolbox Phase II are important elements 
that will have a significant impact on the use of OSIRIS Frame-
work outputs. 
The Framework has to be easily accessible, and user friendly. That 
means among others that the input information should be clearly 
captured, that the algorithms used are transparent, that the results 
are reproducible, and the outputs formatted in such a way that 
they are ready for use in REACH. Finally, OSIRIS should develop 
a vision how to deal with end-users when questions arise, or 
when bugs are discovered, and also how it will ensure sustained 
development, support and maintenance for the tool.   
A business plan is needed to deal with many, if not all, of the 
above challenges. Without such a plan I expect that OSIRIS will 
deliver scientific developments for an R&D environment, not a 
regulated one. 
2.4.4 Results of the plenary discussion 
The plenary discussion after the presentations focussed on the 
following main points and open questions: 
 
Uncertainty of testing strategies 
 Industry takes a special view on uncertainty. If a test is legally 
accepted, than it is regarded as reliable.  
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 Uncertainty relates to a social construct: certainty or safety are 
both social constructs. This means: these are mental instru-
ments to explain variability of results without knowing the 
exact cause for each variation. There is always uncertainty in-
volved in every testing (false negative/ false positive).  
 Science-based risk assessments are not sufficient for evaluat-
ing and managing risks. It's a question of how much uncer-
tainty one is willing to accept. There is a need of an integrated 
concept that links: 
 risk assessment with risk perception and socio-cultural 
processing of risk  
 physical risk analysis with financial, economic and social 
risk  
 risk theory with organizational capacity building and man-
agement competency. 
 Is uncertainty greater when using animal testing or ITS?  
 
Available and sharing data 
 Data from industry is needed both to develop the ITS in 
OSIRIS and meet the requirements of REACH. Sharing data 
will be one of the important factors in reducing animal test 
and costs. The problem is that some partners, mostly the in-
dustry, must see a benefit if they agree to share data with oth-
ers. They have to provide data continuously for research and 
OSIRIS will rely on continuous data flows for their webtool. 
Therefore data transfer and sharing should be harmonized 
and be obligatory for all actors. This is in the best interest of 
the public. However, on should respect that some sort of sen-
sible data is proprietary and will not leave companies.  
 
 
 
Benighaus (Ed.): Stakeholder Involvement and Dissemination 81 
 
 
Selecting endpoints 
 It was discussed why sensitisation and mutagenicity were 
selected as endpoints instead of reproductive toxicity. On the 
first Expert Workshop, reproductive toxicity got the highest 
ranking, too, because of the number of animals and costs in-
volved. But it was argued that a lot of animal testing is also 
necessary in the case of sensitisation. In addition, there is 
more data available for sensitisation than for reproductive 
toxicity. This is certainly an important point in developing 
ITS. Mutagenicity was selected because a great amount of in 
vitro data are already available. 
 The participants raised the question whether two generation 
testing is much more valid than one generation testing. Is 
there a great loss of information when performing a one gen-
eration test only? A result of one study does not confirm this 
hypothesis, but this must be more validated. 
 
Setting priorities of chemicals and endpoints 
 OSIRIS should take into account the extent of coverage of 
‚chemical space‛ rather than considering chemicals individu-
ally. This could be important to determine testing priorities as 
a basis to advance testing methodologies. 
 There was support for the idea of including as many lists and 
endpoints as possible. However, resources (e.g. budget, time) 
are limited. The question might be: Which endpoints should 
be considered?
6
 OSIRIS researchers pointed out that, at the 
beginning, the focus was on a narrow selection of lists and 
endpoints. This choice will be broadened further as the pro-
ject proceeds. 
                                                          
6
 This is a point that was already being discussed at the first Expert 
Workshop (see results in the report on the OSIRIS homepage, 
http://www.osiris.ufz.de/). 
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Learning from other projects and using their routines 
 It was advised that OSIRIS should avoid doing research that 
has been done before in other projects but instead go beyond 
that. OSIRIS researchers pointed out that research findings of 
other relevant projects are considered in a routinized manner 
and all relevant studies will be taken into account. 
 OSIRIS can perhaps learn from other similar projects. For 
example, the question was raised of how many cases of the 
23.000 analyzed substances of the Canadian research program 
QSARs turned out to be relevant. Although exact figures are 
not available, one can assume that it was quit a great amount. 
QSARs could become a promising perspective for OSIRIS, 
too. Actually, it was emphasized that, in the first two years of 
the project, QSARs will be developed and made ready for 
easy access. Additionally approaches of ITS will be incorpo-
rated for the ongoing work in OSIRIS. 
 
Open question, which should be taken into account by OSIRIS: 
 OSIRIS should consider the political dimension in the ques-
tion of acceptance of ITS by for example ECHA, Member 
States or the EC. How can acceptance by these European and 
governmental institutions be best achieved? 
 The goal of OSIRIS is not to write deliverables but also to 
circulate testing methods and make them acceptable and us-
able by different stakeholders. What can be delivered by 
OSIRIS and in what time? How do the timelines of OSIRIS 
and REACH match?  
 What will come after 2011 when the funding from the EC will 
stop at end of the project? Will OSIRIS simply end? What will 
come after the OSIRIS project and who will support and take 
care of the web tool? Will it be an open source product which 
everybody is allowed to use and update? 
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2.4.5 Results of the World Café 
According to the World Café, the participants discussed three 
main questions at different tables. After three rounds the table 
hosts summarized the results on three flip charts separately for 
each question. These three flip-overs are presented below.  
Question 1: Under which conditions are the proposed integrated 
testing strategies operational for being used under REACH? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Flip-over 1 
Basics: 
 Models must be available 
 Comparable substances (data) are crucial 
 Basic knowledge about specific substance. 
Other conditions: 
 model transparency 
 transparency of weight of evidence (incl. waiving) 
 scientific sound basis 
 interaction between stakeholders 
 dissemination, communication and training 
 easy to use, costs 
 for all stakeholders: confidence in the ITS 
 ITS with classification DNEL, DMEL, PNEC 
 Data base needs to include human data (epidemiological, 
etc.) 
 ITS tools must be available 
 substance should fit into a domain of applicability of the 
model. 
Open question: Is regulatory acceptance a formal adoption proc-
ess? 
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Question 2: Is the pool of existing information sufficient to 
conduct integrated testing strategies and if not, which addi-
tional information needs to be accumulated? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Flip-over 2 
Is it true that the majority of chemicals no data exists? 
 
One has to differentiate three options: 
 Volumes: Chemicals are produced in very different amounts 
of tonnes. If considering only the chemicals with high vol-
ume, there is data available. For 75% of the chemicals volu-
mes data do exist. 
 Number of substances: If considering the absolute number of 
substances, there is no data for a lot of single substances. 
 Endpoints: Only if we know all possible endpoints we can 
say, that there is enough data or not. Do we know them all? 
 
There is a contradiction: On the one hand, data gaps are minimal 
considering volumes (active groups). On the other hand, basic 
data is missing for a lot of substances (rest of substances). Besides 
ITS are already being used with the data available (Testing Strat-
egy Steer). 
Some elements of ITS aren't as new, superior or different from 
well known practices as is being assumed. For example, a QSAR 
is a formalized expert judgement. 
 
Recommendation: Definition of QA/QC (quality criteria) for new 
test methods, old none GLP-data, etc. 
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Additionally, there are some individual statements by members 
of the group studying this question: 
 It is not sufficient. There are data that are not public. Compa-
nies have to share these data but they need to be confident on 
the ‚downstream users‛ of data. 
 It is too early to say if adequate data exists for ITS. 
 The suitability of ITS depends on the substance class and the 
selected endpoint. 
 As technologies continue developing, the existing data will 
never be sufficient. 
 How to assess complex mixtures (e.g. natural oils)? 
 Easier for local rather than systemic effects. 
 In case of lack/insufficient information, more information 
needs to be generated on the Mode of Action. 
 Evaluation framework can be highly subjective, e.g. we need 
more transparency about current Risk Assessment methods. 
 There should be a common sense about the endpoints com-
panies and scientists are working with. 
 Access to alternative test methods should be possible (in addi-
tion to OECD etc. as the validation takes years). 
 Read-across – grouping of chemicals by SA/ QSAR, Mode of 
action, Pharmakokinetics 
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Question 3: Can you reduce the amount of testing, especially 
animal testing (reducing costs and time) without sacrificing 
accuracy, validity and reliability of the results? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Flip-over 3 
Accuracy, Validity and Reliability of the Golden Standard? 
 
 Surrogate for human test, uncertainty is there, so you can 
adopt ITS as well. 
 
Can we reduce the amount of testing strategies? 
Yes, we can under three conditions:  
 use contextual information  
 category data 
 read across  
 Mode of Action information 
 combine endpoint with specific test, for example RDT and in 
vivo mutagenicity  
 use early indicators instead of ‚late‛ indicators, shorten ex-
posure of animals to chemicals.  
 
 needs category – ITS 
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2.5 Conclusion 
The implemented guidelines of REACH require a new strategy to 
minimise the use of animals in testing methods. Gerrit Schüür-
mann explained in the context of the project the principle of Hu-
mane Experimental Technique from Russell and Burch (1959)7 
‚3Rs‛ (reduce, replace and refine animal testing) which is interna-
tionally accepted and promoted in the partnership between the 
European Commission and industry (EPAA). The industry un-
derstands that, for reasons of animal welfare, costs and logistics, it 
is important to limit the number of tests to be conducted. Inte-
grated Testing Strategies (ITS) will give the opportunity to accel-
erate the use of non-testing information for regulatory decisions 
making of chemicals without reducing the required level of 
safety. OSIRIS will develop approaches for the many-to-one re-
placements of animal tests, i.e. Integrated Testing Strategies (ITS). 
But using ITS will not entail one-by-one replacements, but several 
different approaches will be combined and integrated, introduced 
Gerrit Schüürmann. A systemic combination of the testing strate-
gies like in vitro testing, QSAR, read-across or TTC will help to 
develop innovative non-animal approaches. One major require-
ment is to use contextual information with category data, read 
across and Mode of Action information. It was suggested to com-
bine endpoints with specific tests, for example RDT and in vivo 
Mutagenicity. 
 
                                                          
7
 William .M.S. Russell and Rex. L. Burch (1959): The Principles of Hu-
mane Experimental Technique. 
http://altweb.jhsph.edu/publications/humane_exp/het-toc.htm, 
downloaded 9.12.2008 
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Uncertainty of ITS 
An important limiting factor in implementation of the ITS will be 
the level of uncertainty that one is willing to accept when apply-
ing the modified testing strategies. The participants asked if the 
uncertainty boundaries will be higher with the new testing strate-
gies compared to conventional animal tests. But uncertainty is 
involved in all testing methods and cannot be reduced to zero. 
The boundaries of uncertainty associated with traditional testing 
are also not well known in quantitative terms too.  
Industry has a special view on uncertainty: if a test is legally ac-
cepted, than it is regarded as reliable. However, there is no 100% 
safety or reliability with any test method. If something is regarded 
as safe it means that the remaining uncertainties are judged ac-
ceptable to society. It is a judgement rather than a scientific fact. 
The new testing strategies demand a new concept dealing with 
uncertainty. The open question remains of how much uncertainty 
one is willing to accept. The acceptance of uncertainty needs an 
integrated concept that links: 
 risk assessment with risk perception and socio-cultural proc-
essing of risk  
 physical risk analysis with financial, economic and social risk 
 risk theory with organizational capacity building and man-
agement competency. 
 
Priorities in OSIRIS and in time delivery 
OSIRIS should take into account the extent of coverage of ‚chemi-
cal space‛ rather than considering chemicals individually. Look-
ing at chemical spaces can facilitate the selection of testing priori-
ties as a basis to advance testing methodologies. Exposure consid-
erations and in particular use categories are also influential factors 
for ranking chemicals. In fact, the nature and pattern of the 
chemicals’ usage have proven out to be more influential than the 
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volume of the respective substances. It is important to obtain in-
formation on early effects and ‚Modes of Action‛ in the risk as-
sessment process. This information should be linked to a concep-
tual framework like the one developed by the International Life 
Sciences Institute (ILSI). TTC offers potential for priority setting 
(including exposure based waiving) if the process is transparent 
and open for viewing the underlying database on toxicity. There 
is also a potential to identify fairly efficiently those chemicals that 
are relatively ‚non-toxic‛ based on hierarchical considerations of 
available data on hazard and relatively conservative criteria for 
dose-response for relevant endpoints. A tool developed for DSL 
categorization permits efficient identification of approximately 
20% of the chemicals examined as not requiring additional con-
sideration with very limited need of resources. 
OSIRIS efforts should focus on ‘in time delivery’ of its tools and 
approaches targeted at substances with a registration deadline of 
December 2013. In order to be considered as an information 
source for the 2013 substances OSIRIS should be functional al-
ready by end 2010. Deliverance end 2010 does allow the consortia 
to assess applicability & remaining uncertainty of the non-test 
information, and either take the decision whether to accept the 
non-test information as is, or start generation of Annex VII & VIII 
information prior to registration. Within industry these decisions 
are not only made by scientists, who can assess the technical mer-
its of the non-test information, but also by business decision mak-
ers (risk managers). The latter group will have to balance the risk 
of non-acceptance by the authorities in the context of their overall 
business planning. Are they willing and able to accept the resid-
ual uncertainties and the potential that their scientists will have to 
spend (extended) time and resources in interpretation discussions 
with ECHA representatives? 
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Data existence for ITS and REACH 
On the one hand, data gaps are minimal considering volumes 
(active groups). On the other hand, basic data is missing for a lot 
of substances (rest of substances). The adequacy of data is highly 
context- and policy-dependent. ITS are already being used with 
the data available (Testing Strategy Steer). The participants rec-
ommended to define QA/QC (quality criteria) for new testing 
methods, old none GLP-data etc., to decide which data are avail-
able and which data can be used for which purpose. The criterion 
of data ‚quality‛ in the context of development of databases 
should inform predictive tool development. The weight of evi-
dence should be assimilated across broader data sources, taking 
into account factors such as consistency, specificity, biological 
plausibility, etc. 
 
Sharing of Data 
Data from industry is needed both to develop the ITS and for 
meeting the regulatory requirements of REACH. Sharing data will 
be one of the important factors in reducing animal test and costs. 
The problem is that some partners, mostly the industry, must see 
a benefit if they agree to share data with others. In addition, they 
have to provide data continuously for research and OSIRIS will 
rely on continuous data flows for their webtool. Therefore data 
transfer and sharing should be harmonized and be obligatory for 
all actors. This is in the best interest of the public. However, on 
should respect that some sort of sensible data is proprietary and 
will not leave companies. The industry must rely on the confiden-
tiality of potential ‚downstream users‛ of data. As technologies 
continue developing, the existing data will never be sufficient.  
The framework has to be easily accessible, and user friendly. That 
means among others that the input information should be clearly 
captured, that the algorithms used are transparent, that the results 
are reproducible, and the outputs formatted in such a way that 
Benighaus (Ed.): Stakeholder Involvement and Dissemination 91 
 
 
they are ready for use in REACH. Finally, OSIRIS should develop 
a vision how to deal with end-users when questions arise, or 
when bugs are discovered, and also how it will ensure sustained 
development, support and maintenance for the tool. 
 
ITS under REACH conditions 
First and foremost the endpoints addressed in OSIRIS need to 
match the information requirements as stipulated in the different 
annexes of REACH. The challenge lies not with the development 
of non-test approaches for environmental endpoints, or local and 
acute toxicity endpoints. However, repeat dose toxicity is where 
most animals are used. Non-test information is expected to have 
the most significant animal-use reduction potential for reproduc-
tive toxicity assessment.  
For the use of ITS under REACH the transparency of models and 
ITS, especially weight of evidence, is absolutely necessary; other-
wise the stakeholder will have no confidence in the methods. 
OSIRIS has to disseminate and communicate the new methods to 
all interested parties and train the stakeholders to use them prop-
erly. 
Basic knowledge about specific substance and comparable sub-
stances (data) are crucial. The testing strategies should be easy to 
use, have low costs and contain the classification DNEL, DMEL, 
PNEC. Data bases needs to include human data (epidemiological, 
etc.).  
Common sense should be employed to choose the most sensible 
endpoints for academic and industrial research. The evaluation 
framework can be highly subjective, e.g. OSIRIS needs more 
transparency about current Risk Assessment methods. Access to 
alternative test methods should be granted to all interested parties 
(in addition to OECD etc.), as the validation takes years. 
OISRIS should develop a formal weight of evidence (WoE) 
framework for evaluating and documenting ITS and integrating 
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the different types of information. This should be done in a trans-
parent and objective manner. This refers particularly to the quan-
tification of uncertainties and the resolution of conflicting values. 
The two-generation study required by REACH could be replaced 
by an extended one-generation study. As an additional opportu-
nity the use of early indicators instead of ‚late‛ indicators may 
shorten the exposure of animals to chemicals. 
 
Acceptance and sustainability of using ITS 
One goal of OISRIS is to develop ITS and a webtool that will offer 
a wide range of applications beyond the end of the project of 2011. 
To accomplish continuous service and availability of the results of 
OSIRIS it is necessary to gain acceptance by all parties involved in 
the risk assessment process. It was acknowledged that all parties 
will need to embrace a change of mind-set, and transparent soft-
ware tools will need to be openly accessible to all. OSIRIS should 
conceive a practical solution of how the webtool and research 
results could be made available to all interested parties and fur-
ther sustained after the end of the project. For practical reasons, 
the timeline of OISIRIS and REACH should be aligned. 
OSIRIS should consider the political dimension in with respect to 
the acceptance of ITS by, for example, ECHA, Member States or 
the EC. A new integrated concept interrelated with the different 
levels of uncertainty have to be accepted not only from the user 
side (mainly industry) but also from European (ECHA, Member 
States, ECVAM) and Non-European authorities. Hence, OECD 
activities on Mutual Acceptance of Data, and the development 
(Q)SAR Toolbox Phase II are important elements that will have a 
significant impact on the use of OSIRIS Framework outputs. 
 
 
Gaps in the acquisition of exposure 
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According to the legal text of REACH, the possibilities for expo-
sure based waiving are quite limited and the burden of proof is 
very high. Exposure based waiving should be justified by a thor-
ough exposure assessment. It should be determined whether cur-
rent exposure models and measurement data are suitable to esti-
mate exposure accurately in the lower exposure range. When 
valid exposure estimates or measurements are obtained, they 
should be compared to a relevant toxicological threshold to de-
termine whether exposure is below the ‘no further action level’. 
Although some thresholds are available it is still unclear to what 
extent they meet the criteria stated above. This needs to be evalu-
ated. In addition, it needs to be determined whether it is valid to 
assume that exposure to substances in REACH at levels below the 
given thresholds do not pose any (substantial) risk. 
A business plan is needed to deal with many of the above chal-
lenges. The development and assessment process of IST needs 
time. In order to gain confidence and continuous feedback for 
alternative testing methods from stakeholders, an open and 
transparent process is absolutely essential. 
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2.6 Annex: Agenda 
Monday, 17th of November 2008 
8.30 On-site Registration, Coffee and refreshments 
9.30 Welcome and introduction to the OSIRIS framework 
Prof. Dr. Gerrit Schüürmann, Helmholtz Centre for Envi-
ronmental Research - UFZ, Germany 
Dr. Georges Deschamps, European Commission, Brussels, 
Belgium  
Moderation: Prof. Dr. Ortwin Renn & Christina Benighaus, 
DIALOGIK and University of Stuttgart, Germany, Frederic 
Bouder, King’s Centre for Risk Management, King’s College 
London, UK 
9.45 REACH: alternative testing – a new practical ap-
proach 
Evelin Fabjan, European Chemicals Agency -  ECHA, 
Finland  
10.15 Human and environmental toxicity and exposure: 
results and critical points of the OSIRIS framework  
Defend: Mark Cronin, School of Pharmacy and Chemistry, 
Liverpool John Moores University, UK 
Second Defend: Dr. Theo Vermeire, National Institute of 
Public Health and the Environment - RIVM, Bilthoven, The 
Netherlands 
Opponent: Dr. Bette Meek, Chemical Risk Assessment, 
McLaughlin Centre for Population Health Risk Assessment, 
University of Ottawa, Canada 
11.30 Coffee break 
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12.00 Integration of the components in the OSIRIS frame-
work and use in the REACH process: results and 
critical points 
Defend: Dr. Dinant Kroese, Chemical Safety, TNO Quality 
of Life, Zeist, The Netherlands 
Opponent: Dr. Watze de Wolf, Environmental Sciences 
Europe, DuPont, Belgium 
13.15 Lunch 
14.00 World Café/Carousel method: process addressing the 
three leading questions (see below) and the three 
issues addressed in the papers by the opponents: 
- Under which conditions are the proposed integrated testing 
strategies operational for being used under REACH? 
- Is the pool of existing information sufficient to conduct 
integrated testing strategies and if not, which additional 
information needs to be accumulated? 
- Can you reduce the amount of testing, especially animal 
testing (reducing costs and time) without sacrificing accu-
racy, validity and reliability of the results? 
Categorisation of the proposed methods and procedures ac-
cording to relevance and implementability 
15.30 Coffee break 
16.00 Presentation of the Group results 
16.30 Plenary discussion and summary of the results 
Dr. Andrew Worth, European Chemicals Bureau, Ispra, 
Italy 
Prof. Dr. Gerrit Schüürmann, Helmholtz Centre for Envi-
ronmental Research - UFZ, Germany 
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17.00 End of the workshop, closing and farewell address  
Prof. Dr. Gerrit Schüürmann, Helmholtz Centre for Envi-
ronmental Research - UFZ, Germany 
 
